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ABSTRACT
IN SITU AORTIC ROOT IN VITRO TESTING OF
THE STENTED AND STENTLESS
PORCINE AORTIC HEART VALVES
by
Sean Parker
Background - The stent, Delrin® support frame, for porcine heart valves has been blamed for
reduced durability of these valves due to the additional stress caused by the relative stiffness
of the stent. There is a tendency among surgeons to do away with the stent in the aortic
position and use porcine stentless valves which are sewn directly in the aortic position after
removing diseased valve. These stentless valves are extremely difficult to test and no
appropriate holder has been designed for this purpose. New approach for in vitro testing of
these valves has been developed at Sheihigh, Inc., Millburn NJ. The stentless valves are sewn
in real porcine heart; the aortic root is dissected out and the aortic root is connected to a
holder then inserted in the Pulse Duplicator System.
This aortic root is kept fresh with antiseptic solutions but not fixed with
glutaraldehyde since it can become stiffer than the natural aorta.
Method - In vitro hemodynamics, blood flow performance, of porcine bioprostheses
were tested under physiological conditions using the pulse duplicator system. The system is
comprised of a test chamber in which the porcine bioprosthesis is inserted, a pressure
transducer, a flow probe, an amplifier pair, and real time software to analyze the fluid
dynamics of stented and unstented porcine bioprostheses.
Thirteen Shethigh Porcine valves were tested in the Pulse Duplicator System for this
study which include 7 - 25mm valve, 4 stented and 3 stentless, and 6 - 23mm valves, 3 stented
and 3 stentless.
Results - Preliminary results from testing three of each stented and stentless 23mm
valves at a rate of approximately 90 Beats Per Minute (BPM) showed an average of a 6%
increase in the Effective Orifice Area (EOA) of the Stentless bioprosthesis over the standard
Stented bioprosthesis. The EOA ranged from a high of 2.41cm 2 for the 25mm stentless to
a low of 2.18cm 2 for the 25mm stented bioprosthesis. The mean EOA for the stented
bioprostheses was 1.94cm 2 and 2.06cm2 for the stentless bioprostheses.
Conclusion - The series of tests which were performed using aortic roots and sizers
to size the aortic root to implant the valve into the proper size root revealed that sizing the
root is critical when trying to achieve a maximum Effective Orifice Area. Sizing of the
stented valve implanted is not as critical due to the stent providing a predefined area for the
valve, but then there is no means for the valve to distend at high flow rates. The stentless
bioprosthesis is superior to the standard bioprosthesis in the sense there is no stress on the
valve comparable to the stented bioprosthesis. At high flow rates the EOA of the stentless
valve is not limited to the inside diameter of the valve because it is allowed to distend outward
at times of high flow rates. Using stentless valves is of importance at times of high flow rates
in order to eliminate the stenosis, the abnormal narrowing of the orifice, opening, in a heart
valve, which is produced in stented valves.
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CHAPTER 1
INTRODUCTION
1.1 Background Information
The stent, Delrin ® support frame, for porcine heart valves has been blamed for reduced
durability of these valves due to the additional stress caused by the relative stiffness of the
stent. There is a tendency among surgeons to do away with the stent in the aortic position
and to use instead porcine stentless valves which are sewn directly in the aortic position after
removing the diseased valve. Because these valves have no stent they are extremely difficult
to test in bench testing and no appropriate holder has been designed for this purpose. A new
approach for in vitro testing of these valves has been developed at Shelhigh, Inc., Millburn,
NJ. The stentless valves are sewn into a real porcine heart; then the aortic root is dissected
out and the aortic root is connected to a holder which is then inserted in the Pulse Duplicator
System (see section 4.2.1 for a description).
The purpose of this study was to compare the hemodynamic performance of 23mm
diamter and 25mm diameter stented and stentless Shelhigh Porcine Bioprostheses implanted
in an aortic root. These valves were evaluated for hydrodynamic performance during forward
flow, at relatively large flow rates, and low and high pulse rates in a Pulse Duplicator System.
In addition, this study was intended to determine sizing of the aortic annulus for implantation
of the Shelhigh No-React® Unstented Porcine Aortic Xenograft in order to achieve an
optimum Effective Orifice Area and at the same time to have a competent valve.
1
1.2 Obj ective
The specific objectives of the study were:
1. To obtain useful hydrodynamic information (transvalvular volumetric flow
rate and pressure difference relations) from Shelhigh stented and stentless
bioprostheses which were tested under conditions that simulate the dynamic flow
behavior of the normal heart, using a pulse duplicator.
2. To compare the hydrodynamic performance of the stented bioprostheses
to the stentless bioprostheses.
3. To evaluate whether undersizing or oversizing of the stentless valve by one
or two sizes has any hemodynamic consequences.
The test instruments provide for excellent in-vitro testing. The Pulse Duplicator
System provides a study of hydrodynamic performance and the functional performance of
valves under simulated conditions of a natural heart.
CHAPTER 2
DESIGN
2.1 Stented Bioprosthesis
The Shelhigh stented porcine bioprosthesis, shown in figure 1, is an evolutionary third
generation porcine heart valve prosthesis. This xenograft, tissue graft that is made from one
animal species to another, is designed to provide improved hemodynamic function and
increased durability and functional life when used in valve replacement surgery.
The aldehyde-stabilized tissue is fixed under "low pressure" to maintain natural
collagen structure. The pericardial bias strip, a strip of pericardium sewn around the contour
of the valve where the tissue is sutured to the Dacron 4.) cloth, prevents possible valve leaflet 
abrasion which would result in a decrease in the functional life of the valve. A Dacron®
covered acetal homopolymer stent, anatomically shaped for optimum fit in the host annulus,
exhibits no sign of flexion fatigue or stent post deformation after complete in-vitro testing.
Aortic valve models contain a sewing ring, implantation flange, that is positioned for supra-
annular placement of the valve. Intraventricular profile, height of valve exposed in ventricle,
of the mitral valve is minimized by the placement of the implantation flange',
2.2 Stentless Bioprosthesis
The Shelhigh stentless porcine bioprosthesis, shown in figure 2, is of revolutionary design.
It has been constructed to resist distortion and to facilitate implantation. The stentless valve
undergoes the same fixation process as the stented valve.
The Shelhigh stentless aortic valve can resist significant distortion. The two-suture-
lines implantation technique facilitates implantation. The valve is constructed from three
separate porcine non-coronary cusps which are the smallest cusps of a porcine valve. They
are joined together with a unique technique and then covered with pericardium. For
implantation, all the sutures are threaded through the pericardial tissue flanges. The
pericardial tissue flange is a strip of pericardium around the base of the valve used to facilitate
implantation.
The valve is also designed to coapt (the coming together of the cusps) within certain
limits even when the aorta dilates after coming off bypass (or when the pressure in the aorta
rises)'.
4
Figure 1. Drawing of Shelhigh stented porcine bioprosthesis.
Figure 2. Drawing of Shelhigh stentless porcine bioprosthesis.
CHAPTER 3
FLUID DYNAMICS
3.1 Theoretical Analysis of the Flow through Prosthetic Heart Valves
The fluid dynamics of a prosthetic heart valve can be treated analogously to the dynamics of
flow through an area reduction, and hence should be analyzed using the equations of motion
of flow across an orifice'.
An orifice is an aperture through which fluid passes and its thickness (in the direction
of flow) is very small in comparison with its other dimensions'. In a sharp caged (rounded)
orifice there is minimum contact with the fluid and consequently minimum "frictional" effects.
For steady, incompressible flow through an orifice (prosthetic valve) of cross-sectional
area A0, the pressure drop (mm Hg) between spatial points i and j is related to the volumetric
flow rate Q(L/m) by the expression:
where Cd is the discharge coefficient (ratio of the actual discharge to the ideal discharge) and
p is the density of the fluid.
Rearrangement of eq. (I) gives:
Or
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where
where C o is the overall valve drag coefficient.
For steady flow through an orifice (prosthetic valve) of area A O (cm2),
where Δ  p (mm Hg) = pi - pj, and K is a scale or a conversion factor. This expression
constitutes the basis of Gorlin's Hydraulic formula'.
An "Effective Orifice Area" (EOA) can be defined by:
Or
For time dependent flow across an orifice (prosthetic valve), the Bernoulli equation along a
streamline between any two points i and j
6
where p' is the time dependent pressure and prime denotes an ideal quantity, since friction is
neglected; and v is the velocity of flow. The last term in eq. (7) v/t represents the unsteady
nature of the flow, and da is a length element along the streamline.
For one dimensional flow,
where A is the cross-sectional area.
Therefore rearranging eq. (7) gives:
In a real flow the actual pressure drop is larger than ideal due to frictional effects, therefore:
where p(t) is the real time dependent pressure.
It is assumed that the values of Cd obtained from steady flow experiments are applicable to
pulsatile flow at corresponding flow rates.
If L is the distance between the two pressure sampling points, then
7
where A is the average cross-sectional area between i and j.
Therefore:
or
In eq. (13) the first term (RQ 2) on the right-hand-side is the resistive (dissipative) term and
the second (I) is the inductive (inertial) term due to the acceleration of the fluid. Another
term can be added to account for the frictional (viscous) losses (FQ).
As can be seen in eq. (14), the pressure drop across a prosthetic valve is solely dependent
upon valve flow characteristics and independent of the cardiovascular parameters. All three
terms on the right-hand-side contribute to the pressure gradient in the natural valve. However
the sum of all three terms in the normal valve is small. The majority of authors neglect this
frictional term claiming that experience shows it to be small in comparison to the resistive
term, for fluids with relatively minimal viscosity such as water or blood. The analysis which
follows neglects this term. The temporal mean value of eq. (12) is:
8
Where T is the period of integration (systolic, period of cardiac cycle during which the heart
contracts, ejection for aortic valve substitute or diastolic, period between two contractions
of the heart, when the muscle of the heart relaxes and allows the chambers to fill with blood,
frlling period for mitral valve substitute), i.e. the interval of forward flow from Q=0 to Q=0.
From eq. (15) and eq. (12) in which the time average of the last term is zero, and where Q 2
is the mean of the square of flow, then:
and
The Gorlin formula tends to introduce large errors if the flow is not uniform in time (Equation
2), because it does not consider the following:
9
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If the dissipative frictional term were not to be neglected, eq. (16) should be written:
In the event that the orifice area is incorrectly computed using eq. (6) then:
While the correct computation is:
The incorrectly computed area will differ from the correct area by the factor:
This factor is not constant but depends on the flow waveform, but the computed orifice area
will always be erroneously small.
CHAPTER 4
IN VITRO HYDRODYNAMIC CHARACTERISTICS
4.1 The Goals
By using a pulse duplicator that simulates the left side of the heart and circulatory system, the
present study intends to compare and contrast the fluid dynamics of stented and stentless
heart valves under various flow rates.
The goal of this work is three fold:
I)	 To obtain useful hydrodynamic information from valves tested under conditions that
simulate the dynamic flow behavior of the normal heart, using a pulse duplicator.
2) To evaluate the relative hydrodynamic performance of each of the bioprostheses used
in this work.
3) To set up a standard hydrodynamic performance of the stentless bioprostheses.
1 1
4.2 Materials and Methods
4.2.1 The Pulse Duplicator
The pulse duplicator used in this study is shown schematically in figure 3. The Pulse
Duplicator System simulates the left side of the heart. The test chamber ("left atrium" and
"left ventricle") consists of a rigid Plexiglas box, permitting an unobstructed view of the
prosthesis from all aspects. The prosthesis is mounted in a rigid plate that separates atrium
from ventricle via a retaining ring system permitting quick changes of test valves. Fluid leaves
the ventricular chamber along a length of rigid Plexiglas tubing with an adjustable resistance
and a parallel compliant chamber permitting adjustment of the load on the ventricle. Pulsatile
flow is created by a positive displacement piston pump connected to the ventricular outflow
by flexible bellows. Steady flow can be achieved through the test valve, with a pump and a
series of reservoirs, as shown in figure 1. The stroke volume, volume pumped, is determined
by the cylindrical piston of the pump being caused to move back and forth within the
chamber. This stroke volume was set to approximately 75 milliliters and was held constant
for the duration of the testing. All tests were performed using a 0.35% glutaraldehyde
solution (formulated using physiological saline). The glutaraldehyde saline solution is used
to maintain cleanliness of the system, as glutaraldehyde is an excellent sterilant, and the saline
to allow for the electromagentic flow probe to measure flow rates.
The fact that the ventricular outflow tract is rigid up to the flow probe ensures that
the flow passing through the probe and the prosthesis are identical. Atrial and ventricular
pressures were measured by a differential pressure transducer (Validyne DP-45) connected
to the test chambers via stiff tubing. The pressure transducer was connected to a carrier
amplifier and the flow meter was connected to a DC amplifier'.
12
4.2.1.1 Flow and Pressure Measurement: The flow meter used in this experiment was a
square wave electromagnetic type (Carolina Medical Electronics, Inc., model FM501 D,
Winston Salem, NC). The flow probe associated with it contains an electromagnet which
produces a magnetic field across the vessel. The probe operates on the principle of
electromagnetic induction, by measuring the potential difference generated across the flow
channel when a conducting fluid passes through a magnetic field. In general this technique
provides an instrument of high sensitivity and adequate frequency response. The frequency
used with the pulse duplicator was 30 Hz. The signal obtained by the induced voltage is
preamplified and processed by the flowmeter. The transducers give accurate readings within
a range of 5 milliliters/min to 19.99 liters/min.
The flow signal and pressure difference signal were then interfaced to a DC amplifier
and a carrier amplifier. The two amplified signals were then routed from the amplifiers to a
16 channel analog-to-digital (A/D) convertor (Keithley Metrabyte) plugged into an expansion
slot in the computer. The amplifier outputs in the range of -5 volts to +5 volts allow for
maximum resolution in the analog-to-digital signal conversion. In addition, a pulse trigger
in the form of a simple electrical circuit built in the pulse duplicator, was connected to a
digital input channel of the A/D convertor. This trigger allowed for the data collection to
begin at the correct time and also estimate the pulse rate.
13
Figure 3. Diagram of the pulse duplicator. PIP = pressure transducer port; MFLPRB =
mitral flow probe; MV = mitral valve; RES = reservoir; LT = left; AOV aortic valve;
AOFLPRB = aortic flow probe.
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4.2.1.2 Computer Software and Calibration: The software designed for these experiments
made use of a visual programming language, HP VEE. A Keithley Metrabyte A/D convertor
converts the analog signal to a digital signal to be processed by the software and computer.
The above-described system constituted a flexible real-time data-acquisition set-up, where
pulsatile flow and pressure-difference information could be immediately processed and
graphically displayed on the high-resolution screen of the computer.
Using the software as indicated produces reliable and reproducible results. Calibration
of the pressure transducer and flow meter is performed through the icon marked
"Calibration". Information on calibration of the system is instructed to the user on the screen
as they progress through the calibration cycle. Calibration of the system is performed once
initially on start up and then on a periodic basis. Calibration of the pressure transducer is
performed by opening both sides of the transducer to atmosphere and raising the "+" side of
the transducer to a reference pressure of 1 cm of water; this value is then captured on the
screen. The second step is to raise the manometer to a second reference pressure of 14 cm
of water applied again to the "+" side and capture this value. The final step is to return the
transducer to the pulse duplicator, the "+" side to the "atrium" side and the "-" side to the
"ventricle" side of the pulse duplicator. This zero value is then captured on the screen. These
three value are used as a reference for the software in calculating the measured pressures
across the valves.
The flow meter was calibrated at the same frequency as the pressure transducer. A
toggle switch in the flowmeter provided a 1-V signal on mean and pulsatile outputs to
calibrate the external amplifier range (1V corresponded to a flow rate of 10 L/min). As with
the pressure, the flow was calibrated for 0.1V, 1V and zero flow where these three values
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were captured and used as a reference to determine the flow rates. Each analog signal was
digitized at a rate of 1500 samples per second using the A/D convertor.
The pulse rate was calculated through a subroutine devised for this purpose, by using
an on-board high resolution counter, by processing binary data coming from the digital input
channel to which the pulse trigger was routed.
With flow rate, pressure difference, and pulse rate-data available, all other pertinent
parameters (stroke or positive volume, negative or backflow volume, regurgitation fraction,
cardiac output, effective orifice area, discharge coefficient, and performance index) were
immediately calculated within the program. These parameters are defined in Section 4.2.3
Data Calculation and Statistical Analysis. These values, together with the corresponding flow
and pressure waveform curve at every run, were automatically stored in specific files,
displayed on the screen and, if desired, printed. It was possible to recall runs at a later date
for analysis and/or printing.
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4.2.2 Bioprostheses Tested
Thirteen Shelhigh Porcine valves were tested in the pulse duplicator system for this study
which include 7 -25mm valves, 4 stented and 3 stentless , and 6 -23mm, 3 stented and 3
stentless. At least three complete runs of each size and each type (stented or stentless) valve
were performed.
4.2.3 Data Calculation and Statistical Analysis
The hydrodynamic characteristics of the bioprostheses were analyzed by mean pressure drop
as a function of root mean square (rms) pulsatile flow rate. Value: of 1) mean pressure
difference in millimeters of mercury, and 2) root mean square pulsatile flow rate in liters/min
were internally calculated by the data-acquisition software for every run in the pulse
duplicator system. In addition, the following parameters were also internally calculated for
each run: 3) rate (beats/min) in BPM, 4) stroke (positive forward) volume in milliliters, 5)
negative (back flow) volume in milliliters, 6) regurgitation fraction calculated as the percent
regurgitation flow (percent ratio of the negative volume to the positive volume), 7) Effective
Orifice Area (EOA) in square centimeters, 8) Discharge Coefficient (C d), and 9) Performance
Index (PI).
An effective orifice area (EOA), in square centimeters, based on a modification of the
Gorlin formula was calculated ignoring the discharge coefficient (C d = 1).
Two different estimates of EOA were calculated as:
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where 516 is a constant conversion factor, which includes the gravitational constant and the
conversion of pressure units (millimeters of mercury to centimeters of water).
A discharge coefficient (C d) was calculated using the formula:
A performance index (P I ) was calculated according to the formula:
All data were statistically treated as being drawn from a normally distributed
population, with p less than 0.05 being considered significant. Difference between EOA of
Stented and Stentless valves of the same size were identified using Student's t-test7.
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4.3 Protocol
Every bioprosthesis to be tested was evaluated according to the following protocol, using
035% glutaraldehyde solution at room temperature as the testing fluid. Viscous effects were
assumed to be negligible.
Pulse Duplicator
In-vitro hemodynamic tests were performed on each valve with a constant stroke volume and
pulse rates of 60, 70, 80, 90, 100, H O, 120 beats per minute, with a range of error of ± 5
beats per minute.
19
4.4 Results
4.4.1 Pulse Duplicator Testing
Figure 4 shows EOA vs Cardiac Output for Shelhigh Porcine Stented and Stentless
Bioprostheses, 23mm mounting size, tested on the Pulse Duplicator system at the pulse rates
indicated in the protocol.
Figure 5 shows EOA vs Cardiac Output for Shelhigh Porcine Stented and Stentless
Bioprostheses, 25mm mounting size, tested on the Pulse Duplicator system at the pulse rates
indicated in the protocol.
Figure 4 shows EOA vs Cardiac Output for Shelhigh Porcine Stented and Stentless
Bioprostheses, 25mm mounting size, tested on the Pulse Duplicator system at the pulse rates
indicated in the protocol.
Table 1 shows a statistical analysis using a two sample Student t-test of the EOA for
23 and 25mm stented and stentless bioprostheses.
Table 2 shows the Effective Orifice Area of the Shelhigh Porcine Stented and
Stentless Bioprostheses, 23mm, and 25mm mounting size, tested on the Pulse Duplicator
system at the pulse rates indicated in the protocol.
Tables 3 - 9 present the cardiac output (heart rate x stroke volume), flow rates
(measured flow during diastole), pressure (not representative of physiologic system) and
EOA and leakage volume percentage* for each valves tested at rates specified in the protocol
('23'nd '25° represent 23 and 25mm stented valves respectively and `S23 ' and 'S25'
represent 23 and 25 mm stentless valves respectively).
*This is not factual, there is no leakage during valve closure.
4.4.2 Effective Orifice Areas
In this study, effective orifice area (EOA) has been computed for each bioprosthesis using
essentially the Gorlin formula with a discharge coefficient of 1 2 . Table 1 shows the statistical
analyses (t-test) of the differences in the EOA for stented and stentless valves of the same
size. The stented and stentless valves of the same size provide significantly different EOAs.
For all rates tested as specified in the protocol, the 25mm stentless valve provided an average
EOA of 2.41 cm2 while the 25mm stented valve provided an EOA of 2.18 cm 2 . The 23mm
stentless valve provided an average EOA of 2.13 cm 2 while the 25mm stented valve provided
an EOA of 1.91 cm 2 . There is an obvious and statistically significant tendency of EOA to
increase as with the stentless bioprostheses as shown in figure 4 and 5. The significance was
based on the calculation of the p value for the size 23 and 25mm stented and stentless
bioprostheses. A p-value of 0.039 and 0.037 was calculated for the 23 and 25mm
bioprostheses respectively.
Test data sheets for each test run of each valve which include pertinent information
such as stroke volume, cardiac output, flow rates, pressure gradients, regurgitant fraction,
EOA, performance index and additional information are listed in appendix I.
21
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Table 1.	 Two-sample student's t-test for 23 and 25mm stented and stentless
bioprostheses. P value < 0.05 for a one tail t-test is considered significant.
t-Test: Two-Sample Assuming Unequal Variances
23mm Bioprostheses 25mm Bioprostheses
Stented Stentless Stented Stentless
Mean EOA (cm 2) 1.91 2.13 2.18 2.41
Variance 0.06 0.03 0.04 0.05
Observations 7 7 7 7
Hypothesized Mean Difference 0 0
df 11 12
t Stat -1.9376 -1.9471
P(T<=t) one-tail 0.039 0.038
t Critical one-tail 1.80 1.78
Table 2. Overall Effective Orifice Area (EOA) and p-value using a one-tail Student's
t-test of 23 and 25 mm stented (model 100) and stentless (model 2000) aortic
valves mounted in aortic root and tested using the Pulse duplicator system at
rates of 60, 70, 80, 90, 100, 110, and 120 BPM.
Size Effective Orifice Area (EOA) (sq. cm ) p-value
one-tail
Stented Unstented
23 1.91 2.13 .039
25 2.18 2.41 .037
A statistical analysis was performed using a one-tail Student's t-test to
determine the p-value in which a p-value of less than .05 is considered
statistically significant. A p-value of 0.039 and 0.037 was obtained for the
23 and 25 mm valves respectively showing the EOA between stented and
stentless valve are statistically significant.
23
Table 3
Pulse Rate: 60 BPM
Run # CO
(L/m)
Flow
RMS
(L/m)
Flow
mean
(L/m)
Pressure
mean
(mm Hg)
EOA
(sq. cm)
Leakage
Volume
(percent)*
Size
(mm)
1 4.65 11.41 7.67 7.07 1.39 5.31
23
2 4.87 11.94 8.06 5.68 1.62 4.31
3 4.47 10.49 7.21 4.63 1.57 2.93
4
mean 4.66 11.28 7.65 5.79 1.53 4.18
ox 0.16 0.60 0.35 1.00 0.10 0.98
5 5.03 11,09 7.64 3.18 2.01 2.43
25
6 4.76 11.16 7.60 7.16 1.35 2.48
7 4.75 11.55 7.77 3.90 1.89 4.04
8 4.26 10.79 7.17 2.94 2.03 5.10
mean 4.70 11.15 7.55 4.30 1.82 3.51
ox 0.28 0.27 0.23 1.69 0.28 1.12
9 4.60 10.56 7.44 3.15 1.92 5.72
S23
10 4.78 10.11 7.09 2.90 1.92 4.88
11 4.71 10.74 7.41 3.44 1.87 2.73
12 ----
mean 4.70 10.47 7.31 3.16 1.90 4.44
ox 0.07 0.27 0.16 0.22 0.02 1.26
13 4.22 10.60 7.11 2.84 2.03 7.57
S25
14 5.27 12.14 8.44 3.68 2.04 3.09
15 4.40 10.58 7.23 2.67 2.09 6.82
16
mean 4.63 11.11 7.59 3.06 2.05 5.83
ax 0.46 0.73 0.60 0.44 0.03 1.96
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Table 4
Pulse Rate: 70 BPM
Run 4 CO
(L/m)
Flow
RMS
(Um)
Flow
mean
(Um)
Pressure
mean
(mm Hg)
BOA
(sq. cm)
Leakage
Volume
(percent)*
Size
(mm)
1 5.28 13.00 8.69 7.08 1.58 5.02
23
2 5.41 12.97 8.76 5.60 1.77 3.87
3 5.55 12.36 8.63 5.79 1.66 2.58
4
mean 5.41 12.78 8.69 6.16 1.67 3.82
ax 0.11 0.29 0.05 0.66 0.08 1.00
5 5.50 13.01 8.74 5.18 1.85 2.08
25
6 5.72 13.94 9.26 5.37 1.94 2.31
7 5.88 13.83 9.26 4.48 2.11 4.80
8 5.50 13.69 9.08 4.24 2.15 6.93
mean 5.65 13.62 9.09 4.82 2.01 4.03
ax 0,16 0.36 0.21 0.47 0.12 1.99
9 5.52 13.14 9.00 4.71 1.96 3.90
S23
10 4.90 12.12 8.11 3.86 1.99 4.08
11 5.43 12.25 8.36 4,30 1.91 2.39
12 ---- -----
mean 5.28 12.50 8.49 4.29 1.95 3.46
ax 0.27 0.45 0.37 0.35 0.03 0.76
13 5.34 13.65 9.08 4.08 2.18 10.57
S25
14 5.85 13.83 9.35 4.32 2.15 4.56
15 5.10 12.62 8.42 3.54 2.17 5.56
16
mean 5.43 13.37 8.95 3.98 2.17 6.90
ax 0.31 0.53 0.39 0.33 0.01 2.63
5Table 5
Pulse Rate: 80 BPM
Run # CO
(L/m)
Flow
RMS
(L/m)
Flow
mean
(L/m)
Pressure
mean
(mm Hg)
BOA
(sq. cm)
Leakage
Volume
(percent)*
Size
(mm)
1 6.01 ]A.40 9.65 6.61 1.81 0.02
23
2 6.49 15.42 10.37 6.85 1.90 3.72
3 6.56 14.96 10.27 6.51 1.89 1.74
4
mean 6.35 14.93 10.10 6.66 1.87 1.83
ox 0.24 0.42 0.32 0.14 0.04 1.51
5 6.17 14.86 9.86 4.58 2.24 4.18
25
6 6.07 14.82 9.85 8.25 1.67 2.59
7 6.27 15.57 10.29 5.25 2.19 5.55
8 6.41 16.56 10.91 5.35 2.31 1.82
mean 6.23 15.45 10.23 5.86 2.10 3.54
ox 0.13 0.71 0.43 1.41 0.25 1.44
9 6.74 15.24 10.71 5.59 2.08 0.01
S23
10 5.96 14.40 9.64 4.89 2.10 1.17
11 6.38 14.13 9.68 5.16 2.01 2.35
12 ----- ----
mean 6.36 14.59 10.01 5.21 2.06 1.18
ox 0.32 0.47 0.50 0.29 0.04 0.96
13 6.16 16.32 10.65 4.78 2.41 13.03
14 6.82 17.25 11.44 5.32 2.42 6.55
15 6.17 15.92 10.48 4.64 2.39 4.39
16
S25
mean 6.38 16.50 10.86 4.91 2.41 7.99
ax 0.31 0.56 0.42 0.29 0.01 3.67
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Table 6
Pulse Rate: 90 BPM
Run # CO
(L/m)
Flow
RMS
(L/m)
Flow
mean
(L/m)
Pressure
mean
(mm Hg)
EOA
(sq. cm)
Leakage
Volume
(percent)*
Size
(mm)
1 6.46 15.46 10.35 6.93 1.90 0.01
23
2 7.15 16.32 11.12 6.88 2.01 3.22
3 7.64 16.48 11.51 7.75 1.91 2.39
4 -----
mean 7.08 16.09 10.99 7.19 1.94 1.87
ox 0.48 0.45 0.48 0.40 0.05 1.36
5 7.79 16.83 11.65 5.13 2.40 4.20
25
6 6.86 15.99 10.76 5.97 2.11 5.39
7 7.11 16.61 11.29 5.23 2.35 6.03
8 7.13 17.19 11.65 5.56 2.36 0.03
mean 7.22 16.66 11.34 5.47 2.31 3.91
GX 0.34 0.44 0.36 0.33 0.11 2.34
9 7.37 15.72 11.14 5.80 2.11 1.76
S23
10 6.72 15.44 10.53 5.28 2.17 3.21
11 7.33 16.05 10.89 5.59 2.19 2.17
12
mean 7.14 15.74 10.85 5.56 2.16 2.38
GX 0.30 0.25 0.25 0.21 0.03 0.61
13 6.96 17.97 11.91 5.48 2.48 12.63
S25
14 8.05 17.82 12.32 5.48 2.46 6.19
15 6.48 16.78 11.11 4.89 2.45 8.78
16 ----
mean 7.16 17.52 11.78 5.28 2.46 9.20
GX 0.66 0.53 0.50 0.28 0.01 2.65
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Table 7
Pulse Rate: 100 BPM
Run # CO	 Flow	 Flow	 Pressure	 EOA(Urn)	 RMS	 mean	 mean	 (sq. cm)(Urn)	 (Um)	 (mm Hg)
Leakage
Volume(percent)*
Size
(mm)
23IIIIIIIIIIIIIII
16.80 11.57 7.02 2.05 2.04
0.57 0.49 0.64 0.05 1.63
III
16.84 11.73 6.74 2.10 4.95
25
11.77 2.19 2.671 6 ... 985 1 1 ..873 56..24
5.50 2.34 4.81
5.72 2.42 6.91
ox 0.10
17.17 11.89 6.05 2.26 4h84
0.43 0.20 0.48 0.13 1.50
9 8.12 1686 11.94 6.07 2.21 4.56
S23
10 7.78 16.40 11.44 5.57 2.24 4.19
11 8.01 17.37 11.85 6.04 2.28 175
12 -	 - -	 -
mean 7.97 16.88 11.74 5.89 2.24 3.83
ax 0.14 0.40 0.22 0.23 0.03 0.78
13 7.70 18.75 12.58 5.71 2.53 9.47
S25
14 8.80 18.68 13.02 5.66 2.54 5.30
15 7.83 18.43 12.39 5.29 2.59 7.32
16
mean 8.11 18.62 12.66 5.55 2.55 7.36
ox 0.49 0.14 0.26 0.19 0.03 1.70
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Table 8
Pulse Rate: 110 BPM
Run -14,- CO
(L/m)
Flow
RMS
(Urn)
Flow
mean
(L/m)
Pressure
mean
(mm Hg)
EOA
(sq. cm)
Leakage
Volume
(percent)*
Size
(mm)
1 7.96 17.36 7.14 7.14 2.10 0.03
23
2 8.74 18.19 12.53 6.76 2.26 1 .41
3 8.83 18.03 12.62 7.72 2.10 1.21
4
mean 8.51 17.86 10.76 7.21 2.15 0.88
ox 0.39 0.36 2.56 0.39 0.08 0.61
5 8.98 18.74 12.98 5.85 2.50 2.88
25
6 8.54 18.08 12.45 6.34 2.32 3.85
7 8.75 18.11 12.61 5.88 2.41 4.57
8 8.54 19.35 13.16 6.54 2.44 0.02
mean 8.70 18.57 12.80 6.15 2.42 2.83
CYX 0.18 0.52 0.28 0.30 0.07 1.73
9 8.56 17.89 12.52 6.56 2.26 2.51
S23
10 8.04 17.46 11.98 5.93 2.31 3.17
11 8.31 ,17.18 11.95 6.04 2.26 3.16
12 ----- -----
mean 8.30 17.51 12.15 6.18 2.28 2.95
cix 0.21 0.29 0,26 0.27 0.02 0,31
13 8.33 19.86 13.27 6.07 2.60 7.50
S25
14 9.43 20.05 13.88 6.39 2.56 4.60
15 8.79 19.83 13.44 5.99 2.62 4,23
16
mean 8.85 19.91 13.53 6.15 2.59 5.44
GX 0.45 0.10 0.26 0.17 0.02 1.46
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Table 9
Pulse Rate: 120 BPM
Run # CO
(L/m)
Flow
RMS
(L/m)
Flow
mean
(L/m)
Pressure
mean
(mm Hg)
EOA
(sq. cm)
Leakage
Volume
(percent)*
Size
(mm)
1 8.85 19.50 13.23 8.49 2.16 0.00
23
2 9.81 19.88 13.95 8.05 2.26 2.82
3 9.47 19.15 13.44 8.14 2.17 2.78
4
mean 9.38 19.51 13.54 8.23 2.20 1.87
ax 0.40 0.30 0.30 0.19 0.05 1.32
5 9.38 19.44 13.48 6.38 2.49 3.59
25
6 9.40 19.39 13.45 6.91 2.38 3.02
7 9.67 19.80 13.81 6.66 2.48 3.98
8 9.35 20.56 14.09 9.65 2.14 4.30
mean 9.45 19.80 13.71 7.40 2.37 3.72
ox 0.13 0.47 0.26 1.31 0.14 0.48
9 9.09 18.94 13.22 6.97 2.32 4.95
S2,3
10 8.98 19.05 13.06 6.59 2.40 4.05
11 9.51 19.33 13.44 6.80 2.39 2.40
12 -	 - -----
mean 9.19 19.11 13.24 6.79 2.37 3.80
ox 0.23 0.16 0.16 0.16 0.04 1.06
13 9.37 22.04 14.78 7.04 2.68 8.76
S25
14 10.11 21.32 14.80 6.99 2.61 4.44
15 9.49 21.81 14.73 6.74 2.71 3.98
16 ----
mean 9.66 21.72 14.77 6.92 2.67 5.73
ax 0.32 0.30 0.03 0.13 0.04 2.15
Tables 3-9
* This leakage volume is an artifact; it is due to the fact that the disks which were used to
mount the aortic root in the pulse duplicator were not sealing completely because nd glue was
used. This "leakage" is due to fluid leaking around the annulus of the aortic root, but not due
to leakage of the valves themselves. There was no real variation in leakage percent among
the valves which were mounted in different size roots. This leakage" is therefore not due
to coaption, the coming together of the cusps, of the valve and thus it is not regurgitation.
Regurgitation of a valve is the backflow of blood through the valve while the valve is in the
closed postion. To confirm the nature of the leakage, a test was performed using a dye to
actually see the leakage of fluid around the annulus due to the imperfect connection of the
disks used to hold the aortic root that were not sealing fully.
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Figure 4. 	 Effective Orifice Area vs Cardiac Output of 23mm Stented and Stentless
Bioprostheses
Graph of EOA vs Cardiac Output for the 23mm stented and stentless
bioprosthesis shows a somewhat parallel trend of a statistically significant
higher EOA for the stentless bioprostheses for all cardiac outputs than the
stented bioprostheses.
Figure 5. 	 Effective Orifrce Area vs Cardiac Output of 25mm Stented and Stentless
Bioprostheses
Graph of EOA vs Cardiac Output for the 25mm stented and stentless
bioprosthesis shows a somewhat parallel trend of a statistically significant
higher EOA for the stentless bioprostheses for all cardiac outputs than the
stented bioprostheses.
CHAPTER 5
CLINICAL DATA
Data of the She'high Stentless Porcine Bioprosthesis implanted clinically shows that smaller
size valves can have a better Effective Orifice Area than larger valves. The Effective Orifice
Area was calculated using 2-D Echo on a total of 97 implanted valves, 52 stentless valves
and 45 stented valves implanted by Prof. Infantes at Virgen Macarena Hospital - Seville
Spain. Data shows that the stentless valve had an overall higher EOA than the Stented valve.
The Effective Orifice Area ranged from 1.20 to 2.32cm 2 with stentless valves and 1.06 to
2.28cm2 with stented valves, sizes 21 and 29 mm respectively. This clinical data agrees with
the data obtained from in vitro testing of stented and stentless valves. In vitro testing showed
a higher EOA in the stentless valve than in the stented valve. Table 10 shows number of
stentless and stented valves of different sizes implanted as well as the average EOA for each
size.
Table 10. 	 Clinical Data from Virgen-Macarena Hospital-Seville Spain. Comparative
Effective Orifice Area calculated by 2-D Echo.
Size Stentless Valves (O'Brien-Angell) Stented Valves (Angell-Duran)
No. of
implants
EOA
(sq. cm)
s.d.
(sq. cm)
No. of
implants
EOA
(sq, cm)
s.d.
(sq. cm)
21mm 2 1.20 0.4 8 1.06 0.02
23mm 18 2.07 0.7 17 1.50 0.4
25mm 11 1.45 0.5 10 1.48 0.2
27mm 11 2.41 0.7 6 1.73 0.4
29mm 10 2.32 1.0 4 2.28 0.9
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CHAPTER 6
DISCUSSION
The Effective Orifice Area of the Shelhigh Porcine Stented and Stentless Bioprosthesis
determined by the pulse duplicator averaged for all rates and valves tested for each of the
two sizes, demonstrates the Shelhigh stentless valve has a statistically significant higher EOA
than the stented bioprostheses. The Shelhigh stentless 23mm valve with an average EOA of
2.13 cm2 at an average Cardiac Output of 6.7 L/M is 11% higher than Shelhigh stented
valves, a value which is statistically significant. A P value of 0.039 was obtained using a one
tailed t-test, where a P value less than 0.05 is considered to be statistically significant. Also
statistically significant are the Shelhigh 25mm stentless valves with an average EOA of 2.41
cm2 as compared to the Shelhigh 25 mm stented valves with an EOA of 2.18 cm2 . The 25mm
Shelhigh stentless valve has a 10% higher EOA than the stented Shelhigh valve. A P value
of 0.037 was obtained using a one tailed t-test which is considered significant.
Comparison of clinical data of 97 clinically implanted valves, stented and stentless,
using 2-D echocardiogram revealed that the average Effective Orifice Area of the stentless
valve is higher than stented valves It was found that the average Effective Orifice Area of the
stentless valve was higher in all but one size valve, the 25mm stentless valve. The average
EOA for the 25mm valves implanted was 1.45 cm2 and 1.48 cm2, stentless and stented valves
respectively. The cause of the 0.03 cm2 lower EOA in the stentless valve than the stented
valve may be contributed to the sizing of the stentless valves during implantation . Due to the
lack of a fixed orifice in the stentless valve, oversizing of the valve during implantation can
cause relative stenosis and the EOA to be reduced to that of stented valves or less.
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This study in general demonstrates that the Shelhigh stentless bioprosthesis has a
much higher EOA throughout the entire spectrum of flow ates tested than the stented
bioprosthesis. This shows stented bioprostheses produce some degree of obstruction to flow
due to the semi-rigid stent, thus not allowing for the valve to distend fully at times of high
flow rates. The stentless valve, since there is no stent the valve is prone to distend at high
flow rates.
The design of the stented bioprosthesis has some limiting factors, mainly the fixed
orifice. Thus the area available for flow has certain limits. Furthermore, the muscle shelf on
the right cusp causes additional potential for stenosis. The Shelhigh unstented porcine aortic
xenograft composite will not only increase the hemodynamic efficiency to an optimum level,
but it will reduce the stress on the commissures. This "mechanical" advantage is known to
increase the durability of porcine valves. The flow of a composite valve is optimized due to
the design of the valve. This valve, the Shelhigh No-React ® unstented aortic xenograft is a
composite of three porcine aortic valves which have been preserved by a low pressure
aldehyde fixation process. The non coronary leaflets from each of three aldehyde fixed
porcine aortic heart valves are dissected, matched and sutured together with cardiovascular
suture, then covered with pericardium. The resulting composite unstented valve has an
optimum orifice area due to the absence of the septal shelf found on the right coronary leaflet
of the natural porcine aortic valve.
The regurgitant fraction of the valves in some instances appeared higher than others
due to the manner in which the discs that are placed around the aortic annulus are used in the
mounting of the aortic root in the PDS. This process results in imperfect sealing because no
glue is used. These discs may also not have been the proper size, thereby allowing fluid to
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leak back through the discs giving results of high regurgitation. Most of the "leakage" is
recorded as a closing volume. This volume is recorded as "regurgitant" because of the
volume needed to close the valve and even after the valve is closed the soft cusps continue
to move backward. The real regurgitation fraction after the valve is closed is practically zero.
A small amount of fluid might leak around the mounting ring, since it is very difficult to
prevent this leak in a pulse duplicator.
Sizing of the stentless valves became an important factor during this study. The
23mm valve was implanted and tested in different size roots which include, 23, 25 and 27mm
roots. The 25mm valve was implanted and tested in size 25, and 29mm root. This was
performed to compare the results of implanting the same size stentless valve in different size
aorta. The reason for this type of testing is to examine the effects of surgeons oversizing or
undersizing valves during implantation and the effects of remodeling which takes place after
surgery. During surgery, sizing of the aortic root while the patient is on bypass may be
slightly smaller than it would be after the patient is taken off bypass due to the systolic
pressure expanding the aorta. The following was the approach used to undersize the valve
by one size, an aortic root sized to be 25mm using selected sizers with an outer diameter
equivalent to the stated valve size was used for the implantation of a 23mm stentless valve.
Hemodynamics improved slightly; however the valve still appeared to have less than perfect
hemodynamics based on the data obtained and visual inspection of the valve in the aortic root.
Additional testing was done in which a stentless valve was implanted into a root two sizes
larger than the valve. Previously it had been thought that implanting a valve in a larger root
would cause serious regurgitation and inflict a substantial amount of stress on the valve;
however there was no sign of stress on the valve. All three cusps were symmetrical and
36
during testing the valve opened and closed very well. Results of testing showed no significant
regurgitation and an BOA higher than a stented valve of the same size. Results indicate that
even with the dilatation of the aorta after surgery, implanting a stentless valve in an aortic root
one size larger, hemodynamics will be improved over the stented valve. It is apparent from
this study that the Shelhigh stentless valve model 2000, can resist dilatation up to 2 sizes
higher. It is probably better to undersize the valve during implantation as the BOA will be
higher when compared to an oversized valve still no significant regurgitation could be
measured. This is due to the relatively higher coaptation area of the cusps, as well as the
maintenance of the physical integrity of the valve due to the pericardial tissue covering the
valve.
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CHAPTER 7
CONCLUSION
The Shelhigh No-React ® Unstented Porcine Aortic Xenografi found to have an excellent
hemodynamic properties superior to the stented valves. A statistical analysis showed stentless
valves have a significantly higher EOA than stented valves of the same size. The valve can
be undersized and still produce excellent hemodynamic properties better than that of a
stented.
The in-vitro hemodynamic studies were confirmed by clinical comparative findings
that hemodynamic advantages of the stentless valve is not always evident; smaller size valves
can have better hemodynamics than larger valves.
One of the most significant problems of the stentless valve is its propensity for less
than ideal coaption of the cusps leading to high incidence of aortic regurgitation murmur.
Regurgitation murmur can be a sign of reduced durability. This study shows that the Shelhigh
No-React® stentless valve covered with pericardium, even if implanted in larger aortic root
can resist distention or distortion and continue to be competent. Oversizing appears to cause
relative stenosis and the EOA can be reduced significantly. We conclude that the pericardial
cuff gives the valve certain design integrity and more resistance to distortion and dilatation.
Oversizing is not necessary to assure a good coaption. Undersizing can be desirable and
might achieve higher effective orifice areas. This ability to adapt to different size aortic roots
is important when the aorta distends with changes in systolic pressure. Based on the research
of stentless valves it is recommended that surgeons use one size smaller than measured.
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APPENDIX A
TEST DATA SHEETS
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SHELHIGH Inc. Millburn, NJ 07041
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* SHELHIGH Pulse Duplicator System **
Test No. 	 159 	 Valve Type: SHELHIGH 	 Serial No. 	 S1069 	 Valve size: 23 mm 	 Mftml Fos:
Operator 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 61.22 	 bpm
Stroke Volume:
	
7521
	 ml
Cardiac Output 	 4.60 	 L/m 	  -
Duration of valve cycle: 	 0.98 	 sec.
Forward Flow Phase: 	 0.60 	 sec. 61.44 %
Measured Flow (Um): RMS: 	 10.56 	 L/m
Mean: 	 7.44 	 L/m
Peak: 	 12.43	 L/m
Measured Pressures (mm Hg): Mean: 3.15 mm Hg
Peak Pressure: 11.80 mm Hg
Pressure at max flow: 11.62 mm Hg
Valve Parameters Closing Volume: 8.71 ml, 	 11.59 %
Leakage Volume: 4.30 ml, 	 5.72 %
_
Regurgitant Fraction: 17.30 %
Effective Orifice Area (so cm.): Peak: 	 226 Discharge Coefficient 0.612
Mean: 	 1.35 Performance Index: 0.463
RMS: 	 1.92 Efficiency Index: 0.383
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 160 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1069 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 75.38 	 bpm
Stroke Volume: 	 73.23 	 ml
Cardiac Output: 	 5.52 	 L/m  -
Duration of valve cycle: 	 0.80 	 sec.
Forward Flow Phase: 	 0.48 	 sad, 60.71 %
Measured Flow (L/m ): 	 RMS: 	 13.14 L/m
Mean: 	 9.00 L/m
Peak: 	 16.13 L/m
Measured Pressures (mm Hg): 	 Mean: 	 4.71 mm Hg
Peak Pressure: 	 14.17 mm Hg
Pressure at max flow: 	 14.00 mm Hg
Valve Parameters 	 Closing Volume: 	 11.40 ml, 15.57 %
Leakage Volume: 	 2.86 nil, 	 3.90 %
Regurgitant Fraction: 	 19.48 %
Effective Orifice Area (sq cm.): 	 Peak: 	 2.40 	 Discharge Coefficient 	 0.622
Mean: 	 1.34 	 Performance Index: 	 0.471
RMS: 	 1.96 	 Efficiency Index: 	 0.379
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** SHELHIGH Pulse Duplicator System °°
Test No. 	 161 	 Valve Type: SHELHIGH 	 Serial No. 	 S1069 	 Valve sae: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart teRa: 	 84.75 	 bpm
Stroke Volume: 	 79.54 	 ml
Cardiac Output: 	 6.74 	 urn -
Duration of valve cycle: 	 0.71 	 sec.
Forward Flow Phase:
	
0.44 	 sec. 62.21 %
Measured Flow (Um): RMS: 	 15.24 	 Um
Mean: 	 10.71 	 Urn
Peak: 	 18.39 	 Um
Measured Pressures (mm Hg): Mean: 5.59 mm Hg
Peak Pressure: 15.37 min Hg
Pressure at max flow: 13.67 mm Hg
Valve Parameters Closing Volume: 11.11 ml, 	 13.96 %
Leakage Volume: 0.01 ml, 	 0.01 %
Regurgitant Fraction: 13.98 %
Effective Orifice Area (sq cm.): Peak: 	 2.51 Discharge Coefficient: 0.663
Mean: 	 1.46 Performance Index: 0.501
RMS: 	 2.08 Efficiency Index: 0.431
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SHELHIGH Inc. Millburn, NJ 07041
** SHELHIGH Pulse Duplicator System * *
Test No. 	 162 	 Valve Type: SHELHIGH 	 Serial No. 	 51069 	 Valve size: 23 mm 	 Mara! Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 92.59 	 bpm
Stroke Volume: 	 79.64 	 ml
Cardiac Output: 	 7.37 	 Um -
Duration of valve cycle: 	 0.65 	 sec.
Forward Flow Phase: 	 0.42 	 sec. 65.41 %
Measured Flow (Um): RMS: 	 15.72 	 Um
Mean: 	 11.14 	 Um
Peak: 	 20.22 	 Um
Measured Pressures (mm Hg): Mean: 5.80 mm Hg
Peak Pressure: 16.07 mm Hg
Pressure at max flow: 11.45 mm Hg
Valve Parameters Closing Volume: 9.56 ml, 	 12.01 %
Leakage Volume: 1.40 ml, 	 1.76 %
Regurgitant Fraction: 13.77 %
Effective Orifice Area (sq cm.): Peak: 	 2.71 Discharge Coefficient: 0.671
Mean: 	 1.49 Performance Index: 0.507
RMS: 	 2.11 Efficiency Index: 0.438
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 163 	 Valve Type: SHELHIGH 	 Serial No. 	 S1 069 	 Valve stze: 23 mm 	 Mal Post(
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 102.04 bpm
Stroke Volume: 	 79.61 	 ml
Cardiac Output: 	 8.12 	 Urn -
Duration of valve cycle: 	 0.59 	 sec.
Forward Flow Phase: 	 0.39 	 sec. 67.12 %
Measured Flow (Urn): RMS: 	 16.86 	 Urn
Mean: 	 11.94 	 Urn
Peak: 	 22.68 	 Urn
Measured Pressures (mm Hg): Mean: 6.07 mm Hg
Peak Pressure: 16.25 mm Hg
Pressure at max flow: 10.25 mm Hg
Valve Parameters Closing Volume: . 7.55 ml, 	 9.48 %
.
Leakage Volume: 3.63 ml, 	 4.56 %
Regurgitant Fracfion: 14.04 %
Effective Orifice Area (sq cm.): Peak: 	 2.97 Discharge Coefficient: 0.703
Mean: 	 1.57 Performance Index: 0.532
RMS: 	 2.21 Efficiency Index: 0.457
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 164 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1069 	 valve 	 23 mm 	 Mftral Positic :
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 111.11 	 bpm
Stroke Volume: 	 77.06 	 ml
Cardiac Output: 	 8.56 	 urn
Duration of valve cycle: 	 0.54 	 sec.
Forward Flow Phase: 	 0.36 	 sec. 67.41 %
Measured Flow (Urn): RMS: 	 17.89 	 Urn
Mean: 	 12.52 	 Urn
Peak: 	 24.42 	 Urn
Measured Pressures (mm Hg): Mean: 6.56 mm Hg
Peak Pressure: 16.55 mm Hg
Pressure at max flow: 10.22 mm Hg
Valve Parameters Closing Volume: 9.11 ml, 	 11.83 %
Leakage Volume: 1.94 ml, 	 2.51 %
Regurgitant Fraction: 14.34 %
Effective Orifice Area (sq cm.): Peak: 	 3.08 Discharge Coefficient: 0.718
Mean: 	 1.58 Performance Index: 0.543
RMS: 	 2.26 Efficiency Index: 0.465
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 165 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1069 	 Valve size: 23 mm 	 Mitral Positior
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 118.11 	 bpm
Stroke Volume: 	 76.96 	 ml
Cardiac Output: 	 9.09 	 Urn -
Duration of valve cycle: 	 0.51 	 sec.
Forward Row Phase: 	 0.34 	 sec. 67.72 %
Measured Flow (Urn): 	 RMS: 	 18.94 Urn
Mean: 	 13.22 Urn
Peak: 	 25.93 Urn
Measured Pressures (mm Hg): 	 Mean: 	 6.97 mm Hg
Peak Pressure: 	 16.80 mm Hg
Pressure at max flow: 	 10.65 mm Hg
Valve Parameters 	 Closing Volume: 	 6.50 ml, 	 8.44 %
Leakage Volume: 	 3.81 	 ml, 	 4.95 %
Regurgitant Fraction: 	 13.38 %
Effective Orifice Area (sq cm.): 	 Peak: 	 3.17 	 Discharge Coefficient: 	 0.737
Mean: 	 1.62 	 Performance Index: 	 0.557
RMS: 	 2.32 	 Efficiency Index: 	 0.483
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SHELHIGH Pulse Duplicator System * *
Test No. 	 360 	 Valve Type: SHELHIGH 	 Serial No. 	 S1106 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 61.73 	 bpm
Stroke Volume: 	 77.44 	 ml
Cardiac Output: 	 4.78 	 Um -
Duration of vatve cycle: 	 0.97 	 sec.
Forward Flow Phase: 	 0.65 	 sec. 66.82 %
Measured Flow (Urn): RMS:	 10.11 	 Urn
Mean: 	 7.09 	 Um
Peak: 	 12.65 	 Um
Measured Pressures (mrn Hg): Mean: 2.90 mm Hg
Peak Pressure: 11.37 mm Hg
Pressure at max flow: 11.37 mm Hg
Valve Parameters Closing Volume: 2.71 ml, 	 3.50 %
Leakage Volume: 3.78 ml, 	 4.88 %
Regurgitant Fraction: 8.38 %
Effective Orifice Area (sq cm.): Peak: 	 2.40 . Discharge Coefficient: 0.611
Mean: 	 1.35 Performance Index: 0.462
RMS: 	 1.92 Efficiency Index: 0.423
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 361 	 Valve Type: SHELHIGH 	 Serial No.
	
S1106 	 Valve s'rze: 23 mm 	 Mital Positioi
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 69.44 	 bpm
Stroke Volume: 	 70.61 	 ml
Cardiac Output: 	 4.90 	 urn -
Duration of valve cycle: 	 0.86 	 sec.
Forward Flow Phase: 	 0.52 	 sec. 59.91 %
Measured Flow (Urn): RMS: 	 12.12 	 Urn
Mean: 	 8.11 	 Urn
Peak: 	 15.27 	 Urn
Measured Pressures (mm Hg): Mean: 3.86 mm Hg
Peak Pressure: 13.02 mm Hg
Pressure at max flow: 13.02 mm Hg
Valve Parameters Closing Volume: 4.65 rni, 	 6.59 %
Leakage Volume: 2.88 ml, 	 4.08 %
Regurgitant Fraction: 10.67 %
Effective Orifice Area (sq cm.): Peak: 	 2.51 Discharge Coefficient: 0.633
Mean: 	 1.33 Performance Index: 0.479
RMS: 	 1-99 Efficiency Index: 0.428
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 362 	 Valve Type: 	 SHELHIGH
	 Serial No. 	 S1106 	 Valve size: 23 mm 	 Mita' Positio:
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate:
	
81.52
	 bpm
Stroke Volume: 	 73.08 	 ml
Cardiac Output: 	 5.96 	 urn -
Duration of valve cycle: 	 0.74 	 sec.
Forward Flow Phase: 	 0.45 	 sec. 61.11 %
Measured Flow (Urn): RMS: 	 14.40 	 Urn
Mean: 	 9.64 	 Urn
Peak: 	 18.72 	 Urn
Measured Pressures (rnm Hg): Mean: 4.89 mm Hg
Peak Pressure: 14.60 mm Hg
Pressure at max flow: 14.30 mm Hg
Valve Parameters Closing Volume: 6.83 ml, 	 9.35 %
Leakage Volume: 0.85 ml, 	 1.17 %
Regurgitant Fraction: 10.52 %
Effective Orifice Area (sq cm.): Peak: 	 2.73 Discharge Coefficient: 0.669
Mean: 	 1.41 Performance Index: 0.506
RMS: 	 2.10 Efficiency Index: 0.453
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 363 	 Valve Type: SHELHIGH
	 Serial No. 	 S1106 	 Valve size: 23 mm
	
Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 88.24 	 bpm
Stroke Volume:
	
76.16 	 m l
Cardiac Output:
	
6.72 	 L/m
Duration of valve cycle:
	
0.68 	 sec.
Forward Flow Phase:
	
0.43 	 sec. 63.03 %
Measured Flow (L/m): RMS: 	 15.44 	 L/m
Mean: 	 10.53
	
L/m
Peak: 	 20.07 	 L/m
Measured Pressures (mm Hg): Mean: 5.28 mm Hg
Peak Pressure: 14.87 mm Hg
Pressure at max flow: 14.17 mm Hg
Valve Parameters Closing Volume: 5.76 ml, 	 7.57 %
Leakage Volume: 2.45 ml, 	 3.21 %
Regurgitant Fraction: 10.78 %
Effective Orifice Area (sq cm.): Peak: 	 2.82 Discharge Coefficient: 0.690
Mean: 	 1.48 Performance Index: 0.522
RMS: 	 2.17 Efficiency Index: 0.466
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 364 	 Valve Type: SHELHIGH 	 Serial No. 	 S1106 	 Valve size: 23 mm 	MItral
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 96.77 	 bpm
Stroke Volume:
	
80.40 	 ml
Cardiac Output: 	 7.78 	 L/m
Duration of valve cycle: 	 0.62 	 sec.
Forward Flow Phase: 	 0.42 	 sec. 67.11 %
Measured Flow (Um): RMS: 	 16.40 	 L/m
Mean: 	 11.44 	 L/m
Peak: 	 21.86 	 L/m
Measured Pressures (mm Hg): Mean: 5.57 mm Hg
Peak Pressure: 15.50 mm Hg
Pressure at max flow: 7.82 mm Hg
Valve Parameters Closing Volume: 4.52 ml, 	 5.62 %
Leakage Volume: 3.37 ml, 	 4.19 %
Regurgitant Fraction: 9.81 %
Effective Orifice Area (sq cm.): Peak: 	 2.99 Discharge Coefficient: 0.714
Mean: 	 1.57 Performance Index: 0.540
RMS: 	 2.24 Efficiency Index: 0.487
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* * SHELHIGH Pulse Duplicator System * *
Test No.
	 365 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1106 	 Valve size: 23 mm 	Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 104.90 bpm
Stroke Volume: 	 76.67 	 ml
Cardiac Output: 	 8.04 	 L/m -
Duration of valve cycle: 	 0.57 	 sec.
Forward Flow Phase: 	 0.38 	 sec. 6620 %
Measured Flow (L/m): 	 RMS: 	 17.46 L/m
Mean: 	 11.98 L/m
Peak: 	 23.84 L/m
Measured Pressures (mm Hg): 	 Mean: 	 5.93 mm Hg
Peak Pressure: 	 15.90 mm Hg
Pressure at max flow: 	 9.62 mm Hg
Valve Parameters 	 Closing Volume: 	 4.88 	 6.36 %
• 	 Leakage Volume: 	 2.43 ml, 	 3.17 %
Regurgitant Fraction: 	 9.53 	 %
Effective Orifice Area (sq cm.): 	 Peak: 	 3.16 	 Discharge Coefficient: 	 0.736
Mean: 	 1.59 	 Performance Index: 	 0.557
RMS: 	 2.31 	 Efficiency Index: 	 0.504
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 366 	 Valve Type: SHELHIGH 	 Serial No. 	 S1106 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
Measured Flow (Um):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
Heart Rate:
Stroke Volume:
Cardiac Output:
Duration of valve cycle:
Forward Flow Phase:
RMS: 	 19.05L/m
Mean: 	 13.06 L/m
Peak: 	 25.95 L/m
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 3.27
Mean: 	 1.64
RMS: 	 2.40
	115.38
	 born
	
77.86 	 m l
	
8-98 	 L/m
	
0.52 	 sec.
	
0.35
	 sec. 67.72 %
6.59 mm Hg
16.45 mm Hg
5.52 mm Hg
3.56 	 ml,
3.15
8.62 %
Discharge Coefficient:
Performance Index:
Efficiency index:
4.57 %
4.05 %
0.763
0.577
0.527
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* SHELHIGH Pulse Duplicator System * *
Test No. 	 351 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1108 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 63.56 	 bpm
Stroke Volume: 	 74.14 	 ml
Cardiac Output: 	 4.71 	 L/m  -
Duration of valve cycle: 	 0.94 	 sec.
Forward Flow Phase: 	 0.60 	 sec. 63.06 %
Measured Flow ( L/m ): RMS: 	 10.74 	 L/m
Mean: 	 7.41 	 L/m
Peak: 	 13.17 	 L/m
Measured Pressures (mm Hg): Mean: 3.44 mm Hg
Peak Pressure: 12.02 mm Hg
Pressure at max flow: 11.95 mm Hg
Valve Parameters Closing Volume: 2.35 ml, 	 3.17 %
- Leakage Volume: 2.02 ml, 	 2.73 %
Regurgitant Fraction: 5.90 %
Effective Orifice Area (sq cm.): Peak: 	 2.29 Discharge Coefficient: 0.595
Mean: 	 1.29 Performance index: 0.450
RMS: 	 1.87 Efficiency Index: 0.423
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 352 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 S1108 	 Valve size: 23 mm 	Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	
71.77 	 bpm
	
75.62 	 ml
	
5.43 	 L/m  -
	
0.84 	 sec.
	
0.54 	 sec. 64.29 %
Measured Flow (L/m ):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
Heart Rate:
Stroke Volume:
Cardiac Output:
Duration of valve cycle:
Forward Flow Phase:
RMS: 	 12.25 L/m
Mean: 	 8.36 L/m
Peak: 	 16.56 L/m
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 2.58
Mean: 	 1.30
RMS: 	 1.91
4.30
14.05
13.80
mm Hg
mm Hg
mm Hg
2.41 ml, 3.18 %
1.81 ml, 2.38 %
5.58 %
Discharge Coefficient: 0.607
Performance Index: 0.459
Efficiency Index: 0.434
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* * SHELHIGH Pulse Duplicator System **
Test No.
	 353 	 Valve Type: SHELHIGH 	 Serial No. 	 S1108 	 Valve size: 23 mm 	 Mitral Posit:
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 81.97 	 bpm
Stoke Volume: 	 77.79 	 ml
Cardiac Output: 	 6.38 	 L/m  -
Duration of valve cycle: 	 0.73 	 sec.
Forward Flow Phase: 	 0.48 	 sec. 65.12 %
Measured Flow ( L/m ): 	 RMS: 	 14.13 L/m
Mean: 	 9.68 L/m
Peak: 	 18.87 L/m
Measured Pressures (mm Hg):
	 Mean: 	 5.16 mm Hg
Peak Pressure: 	 15.15 mm Hg
Pressure at max flow: 	 14.32 mm Hg
Valve Parameters 	 Closing Volume: 
	
1J5 ml, 2.25 %
Leakage Volume: 	 1.83 	 ml, 	 2.35 %
Regurgitant Fraction: 	 4.60 	 %
Effective Orifice Area (sq cm.): 	 Peak: 	 2.68 	 Discharge Coefficient: 	 0.639
Mean: 	 1.38 	 Performance Index: 	 0.483
RMS: 	 2.01 	 Efficiency Index: 	 0.461
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 354 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 S1108 	 Valve size: 23 mm 	Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 96.15 	 bpm
Stroke Volume: 	 76.19 	 ml
Cardiac Output: 	 7.33 	 L/m  -
Duration of valve cycle: 	 0.62 	 sec.
Forward Flow Phase: 	 0.41 	 sec. 66.46 %
Measured Flow ( L/m ): 	 RMS: 	 16.05 L/m
Mean: 	 10.89 L/m
Peak: 	 21.18 L/m
Measured Pressures (mm Hg):
	 Mean: 	 5.59 mm Hg
Peak Pressure: 	 15.90 mm Hg
Pressure at max flow: 	 14.15 mm Hg
Valve Parameters
	 Closing Volume: 	 2.38 ml,	 3.12 %
Leakage Volume: 	 1.65 	 ml, 	 2.17 %
Regurgitant Fraction: 	 5.29 	 %
Effective Orifice Area (sq cm.):
	
Peak: 	 2.89 	 Discharge Coefficient: 	 0.698
Mean: 	 1.49 	 Performance Index: 	 0.527
RMS: 	 2.19 	 Efficiency Index: 	 0.500
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* * SHELHIGH Pulse Duplicator System * *
Test No.
	 355 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 S1 108 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
102.74 bpm
Stroke Volume: 	 77.99 	 ml
Cardiac Output: 	 8.01 	 L/m  -
Duration of valve cycle: 	 0.58 	 sec.
Forward Flow Phase: 	 0.39 	 sec. 66.67 %
Measured Flow ( L/m ): RMS: 	 17.37 	 L/m
Mean: 	 11.85 	 L/m
Peak: 	 23.05 	 L/m
Measured Pressures (mm Hg): Mean: 6.04 mm Hg
Peak Pressure: 16.22 mm Hg
Pressure at max flow: 9.90 mm Hg
Valve Parameters Closing Volume: 2.97 ml, 	 3.81 %
Leakage Volume: 2.15 ml, 	 2.75 %
Regurgitant Fraction: 6.57 %
Effective Oiifice Area (sq cm.): Peak: 	 3.03 Discharge Coefficient: 0.726
Mean: 	 1.56 Performance Index: 0.549
RMS: 	 2.28 Efficiency Index: 0.513
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 356 	 Valve Type: SHELHIGH 	 Serial No. 	 S1108 	 Valve size: 23 mm 	Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
104.17 bpm
Stroke Volume:
	
79.79 	 ml
Cardiac Output:
	
8.31 	 L/m
Duration of valve cycle:
	
0.58
	 sec.
Forward Flow Phase: 	 0.39 	 sec. 68.57 %
Measured Flow ( L/m ): RMS: 	 17.18 	 L/m
Mean: 	 11.95 	 L/m
Peak: 	 23.59 	 L/m
Measured Pressures (mm Hg): Mean: 6.04 mm Hg
Peak Pressure: 16.25 mmHg
Pressure at max flow: 9.82 mm Hg
Valve Parameters Closing Volume: 2.66 ml, 	 3.34 %
-
Leakage Volume: 2.52 ml, 	 3.16 %
Regurgitant Fraction: 6.49 %
Effective Orifice Area (sq cm.): Peak: 	 3.10 Discharge Coefficient: 0.718
Mean: 	 1.57 Performance Index: 0.543
RMS: 	 2.26 Efficiency Index: 0.508
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** SHELHIGH Pulse Duplicator System **
Test No. 	 358 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1108 	 Valve size: 23 mm
	
Mitra|
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 118.11	 bpm
Stroke Volume: 	 80.55 	 ml
Cardiac Output:
	
9.51
	 L/m -
Duration of valve cycle: 	 0.51	 sec.
Forward Flow Phase: 	 0.35 	 sec. 69.67 %
Measured Flow (L/m): RMS: 	 19.33 	 L/m
Mean: 	 13.44 	 L/m
Peak: 	 26.30 	 L/m
Measured Pressures (mm Hg): Mean: 6.80 mm Hg
Peak Pressure: 16.62 mm Hg
Pressure at max flow: 7.05 mm Hg
Valve Parameters Closing Volume: 2.49 m l , 	110 %
- Leakage Volume: 1.93 ml, 	 2.40 %
Regurgitant Fraction: 5.50 %
Effective Orifice Area (sq cm.): Peak: 	 3.26 Discharge Coefficient: 0.762
Mean: 	 1.66 Performance Index: 0.576
RMS: 	 2.39 Efficiency Index: 0.544
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 367 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 S1109 	 Valve size: 25 mm
	
Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
61.48
	 bpm
Stroke Volume:
	
68.71
	 ml
Cardiac Output:
	
4.22 	 L/m
Duration of valve cycle: 	 0.98 	 sec.
Forward Flow Phase:
	
0.58 	 sec. 58.94 %
Measured Flow (L/m): RMS:	 10.60 	 L/m
Mean: 	 7.11 	 L/m
Peak: 	 12.51 	 L/m
Measured Pressures (mm Hg): Mean: 2.84 mm Hg
Peak Pressure: 10.80 mm Hg
Pressure at max flow: 10.77 mm Hg
Valve Parameters Closing Volume: 7.36 ml, 	 10.71 %
. Leakage Volume: 5.20 ml, 	 7.57 %
Regurgitant Fraction: 18.28 %
Effective Orifice Area (sq cm.): Peak: 	 2.40 Discharge Coefficient: 0.534
Mean: 	 1.36 Performance Index: 0.414
RMS: 	 2.03 Efficiency Index: 0.338
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 368
	Valve Type:
	
SHELHIGH 	 Serial Na. 	 S1109 	 Valve size: 25 mm 	Mirtral Posttion
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
75.38
	 bpm
Stroke Volume: 	 70.88 	 ml
Cardiac Output: 	 5.34 	 L/m  -
Duration of valve cycle: 	 0.80 	 sec.
Forward Flow Phase:
	
0.46 	 sec. 58.25 %
Measured Flow (L/m ): RMS: 	 13.65 	 L/m
Mean: 	 9.08 	 L/m
Peak: 	 17.35 	 L/m
Measured Pressures (mm Hg): Mean: 4.08 mm Hg
Peak Pressure: 13.60 mm Hg
Pressure at max flow: 13.55 mm Hg
Valve Parameters Closing Volume: 7.57 ml, 	 10.68 %
Leakage Volume: 7.49 ml, 	 10.57 %
Regurgitant Fraction: 21.25 %
Effective Orifice Area (sq cm.): Peak: 	 2.77 Discharge Coefficient: 0.574
Mean: 	 1.45 Performance Index: 0,444
RMS: 	 2.18 Efficiency Index: 0.350
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 370 	 Valve Type: SHELHIGH	 Serial No. 	 S1109 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 80.21 	 bpm
Stroke Volume: 	 76.76 	 ml
Cardiac Output: 	 6.16 	 L/m  -
Duration of valve cycle: 	 0.75 	 sec.
Forward Flow Phase: 	 0.43 	 sec. 57.22 %
Measured Flow ( L/m ): RMS: 	 16.32 	 L/m
Mean: 	 10.65 	 L/m
Peak: 	 20.15 	 L/m
Measured Pressures (mm Hg): Mean: 4.78 mm Hg
Peak Pressure: 14.17 mm Hg
Pressure at max flow: 13.72 mm Hg
Valve Parameters Closing Volume: 	 . 7.90 ml, 	 10.29 %
Leakage Volume: 10.00 ml, 	 13.03 %
Regurgitant Fraction: 23.32 %
Effective Orifice Area (sq cm.): Peak: 	 2.98 Discharge Coefficient: 0.634
Mean: 	 1.57 Performance Index: 0.491
_ RMS: 	 2.41 Efficiency Index: 0.377
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 371 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1109 	 Valve size: 25 mm
	
Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 92.02 	 born
Stroke Volume: 	 75.59	 m l
Cardiac Output: 	 6.96 	 L/m
Duration of valve cycle: 	 0.65 	 sec.
Forward Flow Phase: 	 0.38 	 see. 57.67 %
Measured Flow (L/m): RMS: 	 17.97 	 L/m
Mean: 	 11.91 	 L/m
Peak: 	 20.97 	 L/m
Measured Pressures (mm Hg): Mean: 5.48 mm Hg
• Peak Pressure: 14.50 mm Hg
Pressure at max flow: 11.07 mm Hg
Valve Parameters Closing Volume: 6.96 ml, 	 9.21 %
- Leakage Volume: 9.54 ml, 	 12.63 %
Regurgitant Fraction: 21.84 %
Effective Orifice Area (sq cm.): Peak: 	 2.89 Discharge Coefficient: 0.652
Mean: 	 1.64 Performance Index: 0.505
RMS: 	 2.48 Efficiency Index: 0.395
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** SHELHIGH Pulse Duplicator System * *
Test No.
	 373 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1109 	 Valve size: 25 mm 	 Mital 	 Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 108.70 bpm
Stroke Volume: 	 76.63 	 ml
Cardiac Output: 	 8.33 	 L/m
Duration of valve cycle: 	 0.55 	 sec.
Forward Flow Phase: 	 0.34 	 sec. 61.87 9/0
Measured Flow ( L/m ): RMS: 	 19.86 	 L/m
Mean: 	 13.27 	 L/m
Peak: 	 24.94 	 L/m
Measured Pressures (mm Hg): Mean: 6.07 mm Hg
Peak Pressure: 15.10 mho Mg
Pressure at max flow: 7.55 mm Hg
Valve Parameters Closing Volume: 8.64 ml, 	 11.28 %
Leakage Volume: 5.75 mi, 	 7.60 %
Regurgitant Fraction: 18.78 %
Effective Orifice Area (sq cm.): Peak: 	 3.27 Discharge Coefficient: 0.685
Mean: 	 1.74 Performance Index: 0.530
RMS: 	 2.60 Efficiency Index: 0.431
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 372 	 Valve Type: SHELHIGH 	 Serial No. 	 S1109 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
102.04 bpm
Stroke Volume: 	 75.48 	 ml
Candiac Output: 	 7.70 	 L/m  -
Duration of valve cycle: 	 0.59 	 sec.
Forward Flow Phase: 	 0.36 	 sec. 60.40 %
Measured Flow ( L/m ): RMS: 	 18.75 	 L/m
Mean: 	 12.58 	 L/m
Peak: 	 22.74 	 L/m
Measured Pressures (mm Hg): Mean: 5.71 mm Hg
Peak Pressure: 14.77 mm Hg
Pressure at max flow: 9.05 mm Hg
Valve Parameters Closing Volume: 8.21 ml, 	 10.88 %
Leakage Volume: 7.15 ml, 	 9.47 %
Regurgitant Fraction: 20.35 %
Effective Orifice Area (sq cm.): Peak: 	 3.07 Discharge Coefficient: 0.666
Mean: 	 1.70 Performance Index: 0.516
RMS: 	 2.53 Efficiency Index: 0.411
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 374 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 S1109 	 Valve size: 25 mm
	
Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 120.00 bpm
Stroke Volume: 	 78.09 	 ml
Cardiac Output: 	 9.37 	 Urn -
Duration of valve cycle: 	 0.50 	 sec.
Forward Flow Phase: 	 0.31 	 sec. 62.40 %
Measured Flow (Urn): RMS: 	 22.04 	 Urn
Mean: 	 14.78 	 Urn
Peak: 	 28.33 	 Urn
Measured Pressures (mm Hg): Mean: 7.04 mm Hg
Peak Pressure: 16.12 mm Hg
Pressure at max flow: 9.92 mm Hg
Valve Parameters Closing Volume: 6.32 ml, 	 8.09 %
Leakage Volume: 6.84 ml, 	 8.76 %
Regurgitant Fraction: 16.84 %
Effective Orifice Area (sq cm.): Peak: 	 3.45 Discharge Coefficient: 0.706
Mean: 	 1.80 Performance Index: 0.546
RMS: 	 2.68 Efficiency Index: 0.454
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 234 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 84043 	 Valve size: 25 mm 	Mitral Posit°
Operator: 	 E. Sean Parker
System Parameters:
Measured Row (L/m):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
Heart Rate:
Stroke Volume:
Cardiac Output:
Duration of valve cycle:
Forward Flow Phase:
RMS:	 12.14 L/m
Mean: 	 8.44 L/m
Peak: 	 15.27 L/m
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 2.57
Mean: 	 1.42
RMS: 	 2.04
	66.67	 bpm
	
79.07 	 ml
	
5.27 	 L/m 
-
	0.90 	 sec.
	
0.56	 sec. 61.93 %
3.68 mm Hg
13.22 mm Hg
13.15 mm Hg
4.02 nd . 	5.08 %
2.44 ml, 	 3.09 %
8.17 %
Discharge Coefficient:
Performance Index:
Efficiency Index:
0.537
0.416
0.382
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 238 	 Valve Type: SHELHIGH
	 Serial No. 	 S4043 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
Measured Flow (L/m):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
Heart Rate:
Stroke Volume:
Cardiac Output:
Duration of valve cycle:
Forward Flow Phase:
RMS: 	 13.83 L/m
Mean: 	 9.35 L/m
Peak: 	 17.62 L/m
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 2.74
Mean: 	 1.45
RMS: 	 2.15
	72.46	 bpm
	
80.73
	 ml
	
5.85
	
L/m
	
0.83
	 sec.
	
0.51 	 sec. 62,00 %
4.32 mm Hg
14.02 mm Hg
13.95 mm Hg
4.09 ml; 5.07 cyo
3.68 ml, 4.56 %
9.62 %
Discharge Coefficient: 0.565
Performance Index: 0.438
Efficiency Index: 0.396
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** SHELHIGH Pulse Duplicator System ^^
Test No. 	 242 	 Valve Type: SHELHIGH 	 Serial No. 	 S4043 	 Valve size: 25 mm 	Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 83.80 	 bpm
Stroke Volume: 	 81.40 	 ml
Cardiac Output: 	 6.82 	 L/m  -
Duration of valve cycle:	 0.72 	 sec.
Forward Flow Phase: 	 0.42 	 sec. 58.99 %
Measured Flow ( L/m ): RMS: 	 17.25 	 L/m
Mean: 	 11.44 	 L/m
Peak: 	 21.49 	 L/m
Measured Pressures (mm Hg): Mean: 5.32 mm Hg
Peak Pressure: 15.02 mm Hg
Pressure at max flow: 14.80 mm Hg
Valve Parameters Closing Volume: 2.87 ml, 	 3.53 %
Leakage Volume: 5.33 ml, 	 6.56 %
Regurgitant Fraction: 10.08 %
Effective Orifice Area (sq cm.): Peak: 	 3.01 Discharge Coefficient: 0.635
Mean: 	 1.60 Performance Index: 0.492
RMS: 	 2.42 Efficiency Index: 0.442
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* SHELHIGH Pulse Duplicator System * *
Test No. 	 246 	 Valve Type: SHELHIGH 	 Serial No. 	 S4043 	 Valve size: 25 m m 	Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 96.77 	 bpm
Stroke Volume:
	
83.19 	 ml
Cardiac Output: 	 8.05 	 L/m  -
Duration of valve cycle: 	 0.62 	 sec.
Forward Flow Phase: 	 0.40 	 sec. 64.52 %
Measured Flow ( L/m ): RMS: 	 17.82 	 L/m
Mean: 	 12.32 	 L/m
Peak: 	 23.31 	 L/m
Measured Pressures (mm Hg): Mean: 5.48 mm Hg
Peak Pressure: 15.25 nun Hg
Pressure at max flow: 14.02 mm Hg
Valve Parameters Closing Volume: 3.76 ml, 	 4.53 %
Leakage Volume: 5.15 ml, 	 6.19 %
Regurgitant Fraction: 10.72 %
Effective Orifice Area (sq cm.): Peak: 	 3.22 Discharge Coefficient: 0.647
Mean: 	 1.70 Performance Index: 0.501
RMS: 	 2.46 Efficiency Index: 0.447
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** SHELHIGH Pulse Duplicator System**
Test No. 	 250 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S4043 	 Valve size: 25 m m 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 103.45 	 born
Stroke Volume: 	 85.05 	 ml
Cardiac Output: 	 8.80 	 Urn
Duration of valve cycle: 	 0.58 	 sec.
Forward Flow Phase: 	 0.39 	 sec. 66.67 %
Measured Flow (Urn): RMS: 	 18.68 	 Urn
Mean: 	 13.02 	 Urn
Peak: 	 24.83 	 Urn
Measured Pressures (mm Hg): Mean: 5.66 mm Hg
Peak Pressure: 15.47 mm Hg
Pressure at max flow: 9.07 mm Hg
Valve Parameters Closing Volume: 3.84 ml, 	 4.51 %
Leakage Volume: 4.51 ml, 	 5.30 %
Regurgitant Fraction: 9.81 %
Effective Orifice Area (sq cm.): Peak: 	 3.37 Discharge Coefficient: 0.667
Mean: 	 1 J7 Performance Index: 0.517
RMS: 	 2.54 Efficiency Index: 0.466
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 254 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S4043 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 111.94 	 bum
Stroke Volume: 	 84.22 	 ml
Cardiac Output: 	 9.43 	 L/m  -
Duration of valve cycle: 	 0.54 	 sec.
Forward Flow Phase: 	 0.36 	 sec. 66.92 %
Measured Flow ( L/m ): 	 RMS: 	 20.05 L/m
Mean: 	 13.88 L/m
Peak: 	 26.99 L/m
Measured Pressures (mm Hg):
	 Mean: 	 6.39 mm Hg
Peak Pressure: 	 16.17 mm Hg
Pressure at max flow: 	 10.05 mm Hg
Valve Parameters 	 Closing Volume: 	 3.34 ml, 	 3.97 %
Leakage Volume: 	 3.88 ml, 4.60 %
Regurgitant Fraction: 	 8.57 	 %
Effective Orifice Area (sq cm.):
	
Peak: 	 3.45 	 Discharge Coefficient: 	 0.674
Mean: 	 1.77 	 Performance Index: 	 0.522
RMS: 	 2.56 	 Efficiency Index: 	 0.477
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 258 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 S4043 	 Valve size: 25 mm
	
Mitral Positio
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 123.97 bpm
Stroke Volume:
	
81.58 	 ml
Cardiac Output:
	
10.11
	 L/m  -
Duration of valve cycle: 	 0.48 	 sec.
Forward Flow Phase: 	 0.33 	 sec. 67.21 %
Measured Flow ( L/m ): 	 RMS: 	 21.32L/m
Mean: 	 14.80 L/m
Peak: 	 27.23 L/m
Measured Pressures (mm Hg);
	 Mean: 	 6.99 mm Hg
Peak Pressure: 	 16.62 mm Hg
Pressure at max flow: 	 6.50 mm Hg
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 3.33
Mean: 	 1.81
RMS: 	 2.61
3.38 	 ml, 	 4.15 %
3.62 ml,
	 4.44 %
8.59 %
Discharge Coefficient: 	 0.685
Performance Index: 	 0.531
Efficiency Index:
	
0.485
75
SHELHIGH Inc. Millburn, NJ 07041
** SHELHIGH Pulse Duplicator System * *
Test No. 	 375 	 Valve Type: SHELHIGH 	 Serial No. 	 S1107 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate:
	
62.24 	 loom
Stroke Volume:
	
70.74 	 ml
Cardiac Output: 	 4.40 	 L/m
Duration of valve cycle: 	 0.96 	 sec.
Forward Flow Phase: 	 0.58 	 sec. 60.43 %
Measured Flow (L/m ): RMS:
	
10.58
	 L/m
Mean: 	 7.23 	 L/m
Peak: 	 13.44 	 L/m
Measured Pressures (mm Hg): Mean: 2.67 mm Hg
Peak Pressure: 10.62 mm Hg
Pressure at max flow: 10.60 mm Hg
Valve Parameters Closing Volume: 7.05 ml, 	 9.96 %
. Leakage Volume: 4.83 ml, 	 6.82 %
Regurgitant Fraction: 16.78 %
Effective Orifice Area (sq cm.): Peak: 	 2.66 Discharge Coefficient: 0.550
Mean: 	 1.43 Performance Index: 0.426
RMS: 	 2.09 Efficiency Index: 0.354
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 376 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 S1107 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 72.46 	 bpm
Stroke Volume: 	 70.40 	 ml
Cardiac Output: 	 5.10 	 L/m -
Duration of valve cycle: 	 0.83 	 sec.
Forward Flow Phase: 	 0.50 	 sec. 60.00 %
Measured Flow (L/m): RMS: 	 12.62 	 L/m
Mean: 	 8.42 	 L/m
Peak: 	 16.42 	 L/m
Measured Pressures (mm Hg): Mean: 3.54 mm Hg
Peak Pressure: 12.42 mm Hg
Pressure at max flow: 12.37 mm Hg
Valve Parameters Closing Volume: 10.03 ml, 	 14.24 %
- Leakage Volume: 3.92 ml, 	 5.56 %
Regurgitant Fraction: 18.81 %
Effective Orifice Area (sq cm.): Peak: 	 2.82 Discharge Coefficient: 0.569
Mean: 	 1.45 Performance Index: 0.441
- RMS: 	 2.17 Efficiency Index: 0.354
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** SHELHIGH Pulse Duplicator System ^°
Test No. 	 376 	 Valve Type: SHELHIGH 	 Serial No. 	 S1107 	 Valve size: 25 mm 	 Mitral Poston
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate:
	
85.23 	 bpm
Stro ke Volume:
	
72.38 	 m l
Cardiac Output: 	 6.17 	 Urn -
Duration of valve cycle: 	 0.70 	 sec.
Forward Flow Phase: 	 0.41 	 sec. 58.19 %
Measured Flow (Um): RMS:
	
15.92
	 Um
Mean: 	 10.48 	 Um
Peak: 	 19.94 	 Um
Measured Pressures (mm Hg): Mean: 4.64 mm Hg
Peak Pressure: 13.75 mm Hg
Pressure at max flow: 12.82 mm Hg •
Valve Parameters Closing Volume: 10.78 ml, 	 14.90 %
Leakage Volume: 3.18 ml, 	 4.39 %
Regurgitant Fraction: 19.29 %
Effective Orifice Area (sq cm.): Peak: 	 2.99 Discharge Coefficient: 0.628
Mean:
	 1.57 Performance Index: 0.486
- RMS: 	 2.39 Efficiency Index: 0.392
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 377 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 S1107 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 88.76 	 bpm
Stroke Volume:
	
73.00 	 ml
Cardiac Output: 	 6.48 	 L/m  -
Duration of valve cycle: 	 0.68 	 sec.
Forward Flow Phase: 	 0.39 	 sec. 57.65 %
Measured Flow ( L/m ): 	 RMS: 	 16.78 L/m
Mean: 	 11.11 	 L/m
Peak: 	 20.06 L/m
Measured Pressures (mm Hg): 	 Mean: 	 4.89 mm Hg
Peak Pressure: 	 13.82 mm Hg
Pressure at max flow: 	 12.25 mm Hg
Valve Parameters 	 Closing Volume: 	 7.75 ml, 10.62 %
Leakage Volume: 	 6.41 	 ml, 	 8.78 %
Regurgitant Fraction: 	 19.40 %
Effective Orifice Area (sq cm.): 	 Peak: 	 2.93 	 Discharge Coefficient: 	 0.645
Mean: 	 1.62 	 Performance Index: 	 0.499
RMS: 	 2.45 	 Efficiency Index: 	 0.402
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* * SHELHIGH Pulse Duplicator System *"
Test No. 	 378 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 S1107 	 Valve size: 25 m m 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 102.04 bpm
Stroke Volume: 	 76.70 	 ml
Cardiac Output: 	 7.83 	 L/m  -
Duration of valve cycle: 	 0.59 	 sec.
Forward Flow Phase: 	 0.37 	 sec. 62.33 °./0
Measured Flow (L/m ): RMS: 	 18.43 	 L/m
Mean: 	 12.39 	 L/m
Peak: 	 23.61 	 L/m
Measured Pressures (mm Hg): Mean: 529 mm Hg
Peak Pressure: 14.17 mm Hg
Pressure at max flow: 5.80 mm Hg
Valve Parameters Closing Volume: 8.21 ml, 	 10.70 %
Leakage Volume: 5.62 ml, 	 7.32 %
Regurgitant Fraction: 18.02 %
Effective Orifice Area (sq cm.): Peak: 	 3.31 Discharge Coefficient: 0.680
Mean: 	 1.74 Performance Index: 0.527
RMS: 	 2.59 Efficiency Index: 0.432
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 379 	 Valve Type: SHELHIGH 	 Serial No. 	 S1107 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate:
	
112.78 bpm
Stroke Volume: 	 77.92 	 ml
Cardiac Output: 	 8.79 	 L/m
Duration of valve cycle: 	 0.53 	 sec.
Forward Flow Phase: 	 0.34 	 see.. 64.39 %
Measured Flow ( L/m ): RMS: 	 19.83 	 L/m
Mean: 	 13.44 	 L/m
Peak: 	 26.19 	 L/m
Measured Pressures (mm Hg): Mean: 5.99 mm Hg
Peak Pressure: 14.92 mm Hg
Pressure at max flow: 7.72 mm Hg
Valve Parameters Closing Volume: 8.74 ml, 	 1121 %
Leakage Volume: 329 ml, 	 423 %
Regurgitant Fraction: 15.44 %
Effective Orifice Area (sq cm.): Peak: 	 3.46 Discharge Coefficient: 0.688
Mean: 	 1.77 Performance Index: 0.533
RMS: 	 2.62 Efficiency Index: 0.451
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 380 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 S1107 	 Valve size. 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate:
	
120.97 bpm
Stroke Volume: 	 78.48 	 ml
Cardiac Output: 	 9.49 	 L/m
Duration of valve cycle: 	 0.50 	 sec.
Forward Flow Phase: 	 0.31 	 sec. 63.41 %
Measured Flow ( L/m ): RMS: 	 21.81 	 L/m
Mean: 	 14.73 	 L/m
Peak: 	 28.52 	 L/m
Measured Pressures (mm Hg): Mean: 6.74 mm Hg
Peak Pressure: 15.72 mm Hg
Pressure at max flow: 9.12 mm Hg
Valve Parameters Closing Volume: 8.60 ml, 	 10.96 %
Leakage Volume: 3.12 ml, 	 3.98 %
Regurgitant Fraction: 14.94 %
Effective Orifice Area (sq cm.): Peak: 	 3.55 Discharge Coefficient: 0.714
Mean: 	 1.83 Performance index: 0.553
RMS: 	 2.71 Efficiency Index: 0.470
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** SHELHIGH Pulse Duplicator System **
Test No. 	 16 	 Valve Type: SHELHIGH 	 Serial No. 	 3946 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 61.22 	 bpm
Stroke Volume: 	 74.18 	 ml
Cardiac Output: 	 • 	 4.54 	 L/m
Duration of valve cycle: 	 0.98 	 sec.
Forward Flow Phase: 	 0.60 	 sec. 61.44 %
Measured Flow (L/m):
	 RMS: 	 10.78 L/m
Mean: 	 7.33 L/m
Peak: 	 13.22 L/m
Measured Pressures (mm Hg):
	 Mean:
Peak Pressure:
Pressure at max flow:
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 2.20
Mean: 	 1.22
RMS: 	 1.80
3.76
12.45
12.32
mm Hg
mm Hg
mm Hg
3.20 ml, 4.31 %
3.70 ml, 4.99 %
9.30 %
Discharge Coefficient 0.705
Performance Index: 0.432
Efficiency Index: 0.392
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 17 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3946 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 7426 	 bpm
Stroke Volume: 	 72.52 	 ml
Cardiac Output: 	 5.39 	 L/m
Duration of valve cycle: 	 0.81 	 sec.
Forward Flow Phase: 	 0.49 	 sec. 60.80 %
Measured Flow (L/m): RMS: 	 13.09 	 L/m
Mean: 	 8.77 	 L/m
Peak: 	 16.97 	 L/m
Measured Pressures (mm Hg): Mean: 4.97 mm Hg
Peak Pressure: 14.30 mm Hg
Pressure at max flow: 14.00 mm Hg
Valve Parameters Closing Volume: 4.90 ml, 	 6.76 %
Leakage Volume: 2.52 ml, 	 3.48 %
Regurgitant Fraction: 10.24 %
Effective Orifice Area (sq cm.): Peak: 	 2.46 Discharge Coefficient 0.745
Mean: 	 127 Performance Index: 0.456
RMS: 	 1.90 Efficiency Index: 0.410
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 18 	 Valve Type: SHELHIGH 	 Serial No. 	 3946 	 Valve 	 23 mm 	 Mitral Poston
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 86.21 	 bpm
Stroke Volume: 	 73.57 	 ml
Cardiac Output: 	 6.34 	 L/m
Duration of valve cycle: 	 0.70 	 sec.
Forward Flow Phase: 	 0.42 	 sec. 60.23 %
Measured Flow (L/m ): RMS: 	 15.65 	 L/m
Mean: 	 10.41 	 L/m
Peak: 	 19.13 	 L/m
Measured Pressures (mm Hg): Mean: 5.85 mm Hg
Peak Pressure: 15.10 mm Hg
Pressure at max flow: 13.77 mm Hg
Valve Parameters Closing Volume: 6.45 ml, 	 8.77 %
Leakage Volume: 2.38 ml, 	3_23 %
Regurgftant Fraction: 12.00 %
Effective Orifice Area (sq cm.): Peak: 	 2.55 Discharge Coefficient: 0.821
Mean: 	 1.39 Performance Index: 0.503
RMS: 	 2.09 Efficiency Index: 0.443
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* • SHELHIGH Pulse Duplicator System * "
Test No. 	 19 	 Valve Type: SHELHIGH 	 Serial No. 	 3946 	 Valve 	 23 mm 	 Mitral Position
Operator 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 90.36 	 bom
Stroke Volume: 	 74.83 	 ml
Cardiac Output 	 6.76 	 L/m
Duration of valve cycle: 	 0.66	 sec.
Forward Flow Phase: 	 0.41	 sec. 61.21 %
Measured Flow (L/m): RMS: 	 16.29 	 L/m
Mean: 	 10.91 	 L/m
Peak: 	 20.14 	 L/m
Measured Pressures (mm Hg): Mean: 6.39 mm Hg
Peak Pressure: 15.85 mm Hg
Pressure at max flow: 13.90 mm Hg
Valve Parameters Closing Volume: 4.68 ml, 	 625 %
Leakage Volume: 4.10 ml, 	 5.48 %
Regurgitant Fraction: 11.74 %
Effective Orifice Area (sq cm.): Peak: 	 2.57 Discharge Coefficient 0.818
Mean: 	 1.40 Performance Index: 0.501
RMS: 	 2.08 Efficiency Index: 0.442
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** SHELHIGH Pulse Duplicator System **
Test No. 	 20 	 Valve Type: SHELHIGH 	 Serial No. 	 3946 	 Valve size: 23 mm 	 Mitral Position
Operator 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 101.35 bpm
Stroke Volume: 	 77.43 	 ml
Cardiac Output 	 7.85 	 Um
Duration of valve cycle: 	 0.59 	 sec.
Forward Flow Phase: 	 0.39 	 sec. 66.21 %
Measured Flow (Lim): 	 RMS: 	 17.09 Um
Mean: 	 11.69 Um
Peak: 	 22.48 Um
Measured Pressures (mm Hg):
	 Mean: 	 6.30 mm Hg
Peak Pressure: 	 15.95 mm Hg
Pressure at max flow: 	 9.92 mm Hg
Valve Parameters
	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 2.89
Mean: 	 1.50
RMS: 	 2.20
3.55 ml, 4.59 %
3.07 ml, 3.96 %
8.55 %
• Discharge Coefficient: 0.864
Performance Index: 0.529
Efficiency Index: 0.484
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SHELHIGH Pulse Duplicator System * *
Test No. 	 21 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3946 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 110.29 bpm
Stroke Volume:
	
76.89 	 ml
Cardiac Output 	 8.48 	 Urn
Duration of valve cycle: 	 0.54 	 sec.
Forward Flow Phase: 	 0.37 	 sec. 67.88 %
Measured Flow (Um): 	 RMS: 	 18.02 Urn
Mean: 	 12.31 Urn
Peak: 	 24.20 Um
Measured Pressures (mm Hg): 	 Mean: 	 6.78 mm Hg
Peak Pressure: 	 16.65 mm Hg
Pressure at max flow: 13.57 mm Hg
Valve Parameters 	 Closing Volume: 	 4.15 ml, 	 5.40 %
Leakage Volume: 	 1.44 ml, 	 1.87 %
Regurgitant Fraction: 	 727 %
Effective Orifice Area (sq cm.):
	
Peak: 	 3.00 	 Discharge Coefficient 	 0.878
Mean: 	 1.53 	 Performance Index: 	 0.538
RMS: 	 2.23 	 Efficiency Index: 	 0.499
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 22 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3946 	 Valve size: 23 mm 	Mitre! Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate:
	
121.95 bpm
Stroke Volume: 	 76.59 	 ml
Cardiac Output 	 9.34 	 L/m
Duration of valve cycle: 	 0.49 	 sec.
Forward Flow Phase: 	 0.33 	 sec. 66.94 %
Measured Flow ( L/m ): 	 RMS: 	 20.07 L/m
Mean: 	 13.73 L/m
Peak: 	 25.96 L/m
Measured Pressures (mm Hg):
	 Mean:
	 6.96 mm Hg
Peak Pressure: 	 15.92 mm Hg
Pressure at max flow: 	 11.30 mm Hg
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 3.18
Mean: 	 1.68
RMS: 	 2.46
4.05 ml, 5.29 %
2.13 ml, 2.78 %
8.07 %
• Discharge Coefficient 0.966
Performance Index: 0.592
Efficiency Index: 0.544
89
SHELHIGH Inc. illbum, NJ 07041
** SHELHIGH Pulse Duplicator System **
Test No. 	 37 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 4635 	 Valve size: 23 mm 	 Mitral Position
Operator. 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 63.29 	 bpm
Stroke Volume: 	 73.45 	 m l
Cardiac Output: 	 4.65 	 Um
Duration of valve cycle: 	 0.95 	 sec.
Forward Flow Phase: 	 0.57 	 sec. 60.09 %
Measured Flow (Um): RMS: 	 11.41 	 Um
Mean:
	
7.67 	 Um
Peak: 	 13.18 	 Um
Measured Pressures (mm Hg): Mean: 7.07 mm Hg
Peak Pressure: 16.05 mm Hg
Pressure at max flow: 16.05 mm Hg
Valve Parameters Closing Volume: 6.36 ml, 	 8.65 %
Leakage Volume: 3.90 ml, 	 5 .31 %
Regurgitant Fraction: 13.96 %
Effective Orifice Area (sq cm.): Peak: 	 1.60 Dlscharge Coefficient 0.544
Mean: 	 0.93 Performance Index: 0.333
RMS: 	 1.39 Efficiency Index: 0.287
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 38 	 Valve Type: SHELHIGH 	 Serial No. 	 4635 	 Valve size: 23 m m 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 73.53 	 bpm
Stroke Volume: 	 71.81 	 ml
Cardiac Output 	 528 	 L/m
Duration of valve cycle: 	 0.82 	 sec.
Forward Flow Phase: 	 0.49 	 sec. 60.20 %
Measured Flow ( L/m ): RMS: 	 13.00 	 L/m
Mean: 	 8.69 	 L/m
Peak: 	 15.85 	 L/m .
Measured Pressures (mm Hg): Mean: 7.08 mm Hg
Peak Pressure: 16.85 mm Hg
Pressure at max flow: 16.35 mm Hg
Valve Parameters Closing Volume: 4.59 ml, 	 6.39 %
_
Leakage Volume: 3.60 ml, 	 5.02 %
Regurgitant Fraction: 11.41 %
Effective Orifice Area (sq cm.): Peak: 	 1.92 Discharge Coefficient: 0.620
Mean: 	 1.05 Performance Index: 0.380
RMS: 	 1.58 Efficiency Index: 0.336
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 40 	 Valve Type: SHELHIGH 	 Serial No. 	 4635 	 Valve size: 23 mm 	 Mal Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 83.80 	 bpm
Stroke Volume: 	 71.71 	 ml
Cardiac Output: 	 6.01 	 L/m
Duration of valve cycle: 	 0.72 	 sec.
Forward Flow Phase: 	 0.44 	 sec. 61.58 %
Measured Flow (L/m ): RMS: 	 14.40 	 L/m
Mean: 	 9.65 	 L/m
Peak: 	 17.99 	 L/m
Measured Pressures (mm Hg): Mean: 6.61 mm Hg
Peak Pressure: 16.45 mm Hg
Pressure at max flow: 15.90 mm Hg
Valve Parameters Closing Volume: 7.91 ml, 	 11.03 %
Leakage Volume: -0.01 ml, 	 -0.02 %
Regurgitant Fraction: 11.01 %
Effective Orifice Area (sq cm.): Peak: 	 2.26 Discharge Coefficient 0.711
Mean: 	 1.21 Performance Index: 0.435
RMS: 	 1.81 Efficiency Index: 0.388
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 39 	 Valve Type: SHELHIGH 	 Serial No. 	 4635 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate:
	
89.29
	 bpm
Stroke Volume:
	
72.35 	 ml
Cardiac Output: 	 6.46 	 L/m
Duration of valve cycle: 	 0.67 	 sec.
Forward Flow Phase: 	 0.41	 sec. 61.68 %
Measured Flow (L/m): 	 RMS: 	 15.46 L/m
Mean: 	 10.35 L/m
Peak: 	 19.03 L/m
Measured Pressures (mm Hg):
	 Mean: 	 6.93 mm Hg
Peak Pressure: 	 16.77 mm Hg
Pressure at max flow: 	 15.37 mm Hg
Valve Parameters 	 Closing Volume: 	 7.80 nil, 10.78 %
Leakage Volume:
	
-0.01 ml, -0.01 %
Regurgitant Fraction:	10.77 %
Effective Orifice Area (sq cm.):
	 Peak: 	 2.33 	 Discharge Coefficient: 	 0.745
Mean:
	 1.27 	 Performance Index: 	 0.456
RMS: 	 1.90 	 Efficiency Index: 	 0.407
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 41 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 4635 	 Valve size: 23 mm 	Mrtral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
99.34
	 bpm
Stroke Volume: 	 74.12 	 ml
Cardiac Output: 	 7.36 	 L/m
Duration of valve cycle: 	 0.60 	 sec.
Forward Flow Phase:
	
0.40 	 sec. 66.00 %
Measured Flow ( L/m ): RMS: 	 16.19 	 L/m
Mean: 	 11.01 	 L/m
Peak: 	 21.32 	 L/m
Measured Pressures (mm Hg): Mean: 6.73 mm Hg
Peak Pressure: 16.82 mm Hg
Pressure at max flow: 14.47 mm Hg
Valve Parameters Closing Volume: 7.08 ml, 	 9.56 %
Leakage Volume: -0.00 ml, 	 -0.01 %
Regurgitant Fraction: 9.55 %
Effective Orifice Area (sq cm.):
	
Peak: 	 2.65 	 Discharge Coefficient: 	 0.792
Mean: 	 1.37 	 Performance Index: 	 0.485
RMS: 	 2.02 	 Efficiency Index: 	 0.439
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 42 	 Valve Type: SHELHIGH 	 Serial No. 	 4635 	 Valve size: 23 mm 	Mitral Position
Operator 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 107.91 	 bpm
Stroke Volume: 	 73.80 	 ml
Cardiac Output: 	 7.96 	 L/m
Duration of valve cycle: 	 0.56 	 sec.
Forward Flow Phase: 	 0.37 	 sec. 66.67 %
Measured Flow ( L/m ): RMS: 	 17.36 	 L/m
Mean: 	 11.78 	 L/m
Peak: 	 22.72 	 L/m
Measured Pressures (mm Hg): Mean: 7.14 mm Hg
Peak Pressure: 17.00 mm Hg
Pressure at max flow: 14.55 mm Hg
Valve Parameters Closing Volume: 7.61 ml, 	 10.32 %
Leakage Volume: -0.02 ml, 	 -0.03 %
Regurgitant Fraction: 1029 %
Effective Orifice Area (sq cm.): 	 Peak: 	 2.75 	 Discharge Coefficient 	 0.824
Mean: 	 1.42 	 Performance Index: 	 0.505
RMS: 	 2.10 	 Efficiency Index: 	 0.453
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 43 	 Valve Type: SHELHIGH 	 Serial No. 	 4635 	 Valve size: 23 m m 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 118.11 	 bpm
Stroke Volume: 	 74.96 	 ml
Cardiac Output: 	 8.85 	 Urn
Duration of valve cycle: 	 0.51 	 sec.
Forward Flow Phase: 	 0.33 	 sec. 65.87 %
Measured Flow (Um): 	 RMS:
	
19.50 um
Mean: 	 13.23 Um
Peak: 	 25.49 Um
Measured Pressures (mm Hg):
	 Mean: 	 8.49 mm Hg
Peak Pressure: 	 18.00 mm Hg
Pressure at max flow: 	 16.35 mm Hg
Valve Parameters 	 Closing Volume: 	 7.55 ml, 10.08 %
Leakage Volume: 	 -0.00 ml, -0.00 %
Regurgitant Fraction:	 10.07 %
Effective Orifice Area (sq cm.):
	 Peak: 	 2.83 	 Discharge Coefficlent: 	 0.849
Mean: 	 1.47 	 Performance Index: 	 0.520
RMS: 	 2.16 	 Efficiency Index: 	 0.468
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 72 	 Valve Type: SHELHIGH 	 Serial No. 	 4026 	 Valve size: 23 mm 	 Mitral Posit°
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 66.96 	 bpm
Stroke Volume:
	
72.74
	 ml
Cardiac Output:
	
4.87	 Lim
Duration of valve cycle: 	 0.90 	 sec.
Forward Flow Phase: 	 0.54 	 sec. 59.91 %
Measured Flow (Urn): RMS: 	 11.94	 Um
Mean: 	 8.06 	 Urn
Peak: 	 14.37	 Urn
Measured Pressures (mm Hg): Mean: 5.68 mm Hg
Peak Pressure: 14.70 mm Hg
Pressure at max flow: 14.30 mm Hg
Valve Parameters Closing Volume: 4.48 ml, 	 6.16 %
Leakage Volume: 3.13 ml, 	 4.31 %
Regurgitant Fraction: 10.47 %
Effective Orifice Area (sq cm.): Peak: 	 1.95 Discharge Coefficient 0.636
Mean: 	 1.09 Performance Index: 0.389
RMS: 	 1.62 Efficiency Index: 0.349
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 73 	 Valve Type: SHELHIGH 	 Serial No. 	 4026 	 Valve	 23 mm 	 Mitral Poston
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 74.63 	 born
Stroke Volume: 	 72.46 	 ml
Cardiac Output 	 5.41 	 L/m
Duration of valve cycle: 	 0.80 	 sec.
Forward Flow Phase: 	 0.49 	 sec. 61.11 %
Measured Flow ( L/m ): RMS: 	 12.97L/m
Mean: 	 8.76 	 L/m
Peak: 	 16.62 	 L/m
Measured Pressures (mm Hg): Mean: 5.60 mm Hg
Peak Pressure: 14.97 mm Hg
Pressure at max flow: 14.45 mm Hg
Valve Parameters Closing Volume: 4.21 ml, 	 5.81 %
Leakage Volume: 2.80 ml, 	 3.87 %
Regurgitant Fraction: 9.68 %
Effective Orifice Area (sq cm.): Peak: 	 227 Discharge Coefficient 0.696
Mean: 	 1.20 Performance Index: 0.426
RMS: 	 1.77 Efficlency Index: 0.385
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 74 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 4026 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 86.71 	 bpm
Stroke Volume: 	 74.90 	 ml
Cardiac Output: 	 6.49 	 L/m
Duration of valve cycle: 	 0.69 	 sec.
Forward Flow Phase: 	 0.43 	 sec. 61.90 %
Measured Flow ( L/m ): RMS: 	 15.42 	 L/m
Mean: 	 10.37 	 L/m
Peak: 	 18.89 	 L/m
Measured Pressures (mm Hg): Mean: 6.85 mm Hg
Peak Pressure: 16.62 mm Hg
Pressure at max flow: 15.27 mm Hg
Valve Parameters Closing Volume: 3.22 ml, 	 4.30 %
Leakage Volume: 2.79 ml, 	 3.72 %
Regurgitant Fraction: 8.02 %
Effective Orifice Area (sq. cm .):	 Peak: 	 2.33 	 Discharge Coefficient: 	 0.748
Mean: 	 1.28 	 Performance Index: 	 0.458
RMS: 	 1.90 	 Efficiency Index: 	 0.421
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 75 	 Valve Type: SHELHIGH 	 Serial No. 	 4026 	 Valve 	 23 mm 	 Mitral Posit:
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 92.59 	 bpm
Stroke Volume: 	 77.27 	 ml
Cardiac Output: 	 7.15 	 Urn
Duration of valve cycle: 	 0.65 	 sec.
Forward Flow Phase: 	 0.41 	 sec. 63.52 %
Measured Flow (Um): RMS: 	 16.32 	 Urn
Mean: 	 11.12 	 Urn
Peak: 	 2022 	 Urn
Measured Pressures (mm Hg): Mean: 6.88 mm Hg
Peak Pressure: 16.67 min Hg
Pressure at max flow: 14.82 mm Hg
Valve Parameters Closing Volume: 3.74 ml, 	 4.84
Leakage Volume: 2.49 ml, 	 3.22
Regurgitant Fraction: 8.06 %
Effective Orifice Area (sq cm.):
	
Peak: 	 2.49 	 Discharge Coefficient: 	 0.789
Mean: 	 1.37 	 Performance Index: 	 0.483
• 	 RMS: 	 2.01 	 Efficiency Index: 	 0.444
%%
Effective Orifice Area (sq cm.):
	
Peak: 	 2.86
Mean: 	 1.47
RMS: 	 2.12
Discharge Coefficient 	 0.834
Performance Index: 	 0.511
Efficiency Index: 	 0.470
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 76 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 4026 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 101.35 bpm
Stroke Volume: 	 77.16 	 ml
Cardiac Output: 	 7.82 	 Um
Duration of valve cycle: 	 0.59 	 sec.
Forward Flow Phase: 	 0.40 	 sec. 67.12 %
Measured Flow (Um): RMS: 	 16.66 	 Urn
Mean: 	 11.50 	 Urn
Peak: 	 22.40 	 Um
Measured Pressures (mm Hg): Mean: 6.42 mm Hg
Peak Pressure: 16.02 mm Hg
Pressure at max flow: 12.62 mm Hg
Valve Parameters Closing Volume: 3.14 ml, 	 4.07
Leakage Volume: 3.09 ml, 	 4.00
Regurgitant Fraction: 8.07 %
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 77 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 4026 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 113.64 bpm
Stroke Volume: 	 76.87 	 ml
Cardiac Output:
	
8.74 	 L/m
Duration of valve cycle:
	
0.53
	 sec.
Forward Row Phase: 	 0.36 	 sec. 68.70 %
Measured Flow (L/m): RMS: 	 18.19 	 L/m
Mean: 	 12.53 	 L/m
Peak: 	 25.08 	 L/m
Measured Pressures (mm Hg): Mean: 6.76 mm Hg
Peak Pressure: 16.20 rim Hg
Pressure at max flow: 11.77 mm Hg
Valve Parameters Closing Volume: 3.90 ml, 	 5.08 %
Leakage Volume: 1.08 ml, 	 1.41 %
Regurgitant Fraction: 6.48 %
Effective Orifice Area (sq cm.): 	 Peak: 	 3.12 	 - Discharge Coefficient 	 0.888
Mean: 	 1.56 	 Performance Index: 	 0.544
RMS: 	 2.26 	 Efficiency Index: 	 0.509
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** SHELHIGH Pulse Duplicator System *
Test No.
	 78 	 Valve Type: SHELHIGH 	 Serial No. 	 4026 	 Valve 	 23 mm 	 Mitral Posion
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 122.95 bpm
Stroke Volume: 	 79.82 	 ml
Cardiac Output: 	 9.81 	 L/m
Duration of valve cycle: 	 0.49 	 sec.
Forward Flow Phase: 	 0.34 	 sec. 69.17 %
Measured Flow (L/m ): RMS: 	 19.88 	 L/m
Mean: 	 13.95 	 L/m
Peak: 	 25.92 	 L/m
Measured Pressures (mm Hg): Mean: 8.05 mm Hg
Peak Pressure: 17.55 mm Hg
Pressure at max flow: 11.10 mm Hg
Valve Parameters Closing Volume: 2.34 ml, 	 2.93 %
Leakage Volume: 225 ml, 	 2.82 %
Regurgitant Fraction: 5.76 %
Effective Orifice Area (sq cm.): Peak: 	 2.95 Discharge Coefficient 0.889
Mean: 	 1.59 Performance Index: 0.545
RMS: 	 2.26 Efficiency lndex: 0.513
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 66 	 Valve Type: SHELHIGH 	 Serial No. 	 4022 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 60.48 	 bpm
Stroke Volume: 	 73.98 	 ml
Cardiac Output: 	 4.47 	 L/m
Duration of valve cycle: 	 0.99 	 sec.
Forward Flow Phase: 	 0.61 	 sec. 61.60 %
Measured Flow (L/m): 	 RMS: 	 10.49 L/m
Mean: 	 7.21 	 L/m
Peak: 	 13.22 L/m
Measured Pressures (mm Hg):
	 Mean:
Peak Pressure:
Pressure at max flow:
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak:
	
1.98
Mean: 	 1.08
RMS: 	 1.57
4.63
13.57
13.40
mm Hg
mm Hg
mm Hg
3.66 ml, 4.95 %
2.17 ml, 2.93 %
7.88 %
Discharge Coefficient 0.618
Performance Index: 0.379
Efficiency Index: 0.349
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 87 	 Valve Type: SHELHIGH 	 Serial No. 	 4022 	 Valve size: 23 mm 	 Mitral Poston
Operator: 	 E. Sean Parker
System Parameters:
Measured Flow ( L/m ):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
Heart Rate:
Stroke Volume:
Cardiac Output:
Duration of valve cycle:
Forward Flow Phase:
RMS: 	 12.36 L/m
Mean: 	 8.63 L/m
Peak: 	 16.01 L/m
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 2.15
Mean: 	 1.16
RMS: 	 1.66
	71.43	 bpm
	
77.75 	 ml
	
5.55 	 L/m
	
0.84 	 men.
	
0.54 	 sec. 63.78 %
5.79 mm Hg
15.30 mm Hg
15.02 mm Hg
4.32 ml, 5.56 %
2.01 ml, 2.58 %
8.14 %
Discharge Coefficient
Performance Index:
Efficiency Index:
0.652
0.399
0.367
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 88 	 Valve Type: SHELHIGH 	 Serial No. 	 4022 	 Valve se: 23 mm 	 mitral
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
84.75 	 bpm
Stroke Volume: 	 77.41 	 ml
Cardiac Output
	
6.56
	 L/m
Duration of valve cycle: 	 0.71 	 sec.
Forward Flow Phase: 	 0.45 	 sec. 63.16 %
Measured Flow ( L/m ): RMS: 	 14.96 	 L/m
Mean: 	 10.27 	 L/m
Peak: 	 19.49 	 L/m
Measured Pressures (mm Hg): Mean: 6.51 mm Hg
Peak Pressure: 16.82 mm Hg
Pressure at max flow: 16.00 mm Hg
Valve Parameters Closing Volume: 420 ml, 	 5.42 %
Leakage Volume: 1.35 ml, 	 1.74 %
Regurgitant Fraction: 7.17 %
Effective Orifice Area (sq cm.): Peak: 	 2.47 Discharge Coefficient 0.744
Mean: 	 1.30 Performance Index: 0.455
RMS: 	 1.89 Efficiency Index: 0.423
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* * SHELHIGH Pulse Duplicator System *
Test No. 	 89 	 Valve Type: SHELHIGH
	 Serial No. 	 4022 	 Valve se: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 96.77 	 bpm
Stroke Volume: 	 78.98 	 m l
Cardiac Output: 	 7.64 	 Um
Duration of valve cycle: 	 0.62 	 sec.
Forward Flow Phase: 	 0.41 	 sec. 65.56 %
Measured Flow (Um): 	 RMS: 	 16.48 Urn
Mean: 	 11.51 Um
Peak: 	 21.62 Um
Measured Pressures (mm Hg):
	 Mean: 	 7.75 mm Hg •
Peak Pressure: 	 18.12 mm Hg
Pressure at max flow: 	 14.80 mm Hg
Valve Parameters 	 Closing Volume: 	 4.94 ml, 625 %
Leakage Volume: 	 1.89 ml, 	 2.39 %
Regurgitant Fraction: 	 8.65 	 %
Effective Orifice Area (sq cm.):
	 Peak: 	 2.51	 Discharge Coefficient: 	 0.751
Mean: 	 1.34 	 Performance Index: 	 0.460
RMS: 	 1.91 	 Efficiency Index: 	 0.420
107
SHELHIGH Inc. Millburn, NJ 07041
* * SHELHIGH Pulse Duplicator System * *
Test No. 	 90 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 4022 	 Valve size: 23 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 107.14 	 bpm
Stroke Volume:
	
78.40 	 ml
Cardiac Output:
	
8.40 	 L/m
Duration of valve cycle: 	 0.56 	 sec.
Forward Flow Phase: 	 0.38 	 sec. 67 . 88 %
Measured Flow ( L/m ): RMS: 	 17.56 	 L/m
Mean: 	 1220 	 L/m
Peak: 	 23.95 	 L/m
Measured Pressures (mm Hg): Mean: 7.90 mm Hg
Peak Pressure: 18.15 mm Hg
Pressure at max flow: 14.05 mm Hg
Valve Parameters Closing Volume: 3.96 ml, 	 5.05
Leakage Volume: 1.65 ml, 	 2.10
Regurgitant Fraction: 7.15 %
Effective Orifice Area (sq cm.):
	 Peak: 	 2.75 	 Discharge Coefficient: 	 0.793
Mean: 	 1.40 	 Performance Index: 	 0.486
RMS: 	 2.02 	 Efficiency Index: 	 0.451
%
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** SHELHIGH Pulse Duplicator System *
Test No. 	 91 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 4022 	 Valve size: 23 mm 	Mitral Positon
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 111.11 	 bpm
Stroke Volume:
	
79.47 	 ml
Cardiac Output
	
8.83 	 L/m
Duration of valve cycle: 	 0.54 	 sec.
Forward Flow Phase: 	 0.37 	 sec. 68.94 %
Measured Flow (L/m ): RMS: 	 18.03 	 L/m
Mean: 	 12.62 	 L/m
Peak: 	 24.90 	 L/m
Measured Pressures (mm Hg): Mean: 7.72 mm Hg
Peak Pressure: 17.80 mm Hg
Pressure at max flow: 13.95 mm Hg
Valve Parameters Closing Volume: 4.38 ml, 	 5.51 %
Leakage Volume: 0.96 ml, 	 1.21 %
Regurgitant Fraction: 6.73 %
Effective Orifice Area (sq cm.): Peak: 	 2.90 Discharge Coefficient 0.823
Mean: 	 1.47 Performance Index: 0.504
RMS: 	 2.10 Efficiency Index: 0.470
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** SHELHIGH Pulse Duplicator System **
Test No. 	 92 	 Valve Type: SHELHIGH 	 Serial No. 	 4022 	 Valve size: 23 mm 	Mitral Poston
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 119.05 bpm
Stroke Volume: 	 79.52 	 ml
Cardiac Output: 	 9.47 	 um
Duration of valve cycle: 	 0.50 	 sec.
Forward Flow Phase: 	 0.35 	 sec. 69.35 %
Measured Flow (Um): RMS: 	 19.15 	 Urn
Mean: 	 13.44 	 Um
Peak: 	 25.94 	 Urn
Measured Pressures (mm Hg): Mean: 8.14 mm Hg
Peak Pressure: 18.12 mm Hg
Pressure at max flow: 13.62 mm Hg
Valve Parameters Closing Volume: 2.49 ml, 	 3.13
Leakage Volume: 2.21 ml, 	 2.78
Regurgitant Fraction: 5.92 %
Effective Orifice Area (sq cm.):
	
Peak: 	 2.94 	 Discharge Coefficient 	 0.851
Mean: 	 1.52 	 Performance Index: 	 0.521
RMS: 	 2.17 	 Efficiency Index: 	 0.490
%
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** SHELHIGH Pulse Duplicator System **
Test No. 	 12 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 3494 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
Measured Flow (Urn):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
	
65.50 	 bpm
	
76.83 	 ml
	
5.03 	 um
	
0.92
	 sec.
	
0.60 	 sec. 65.28 %
Heart Rate:
Stroke Volume:
Cardiac Output:
Duration of valve cycle:
Forward Flow Phase:
RMS: 	 11.09 Um
Mean: 	 7.64 Um
Peak: 	 15.66 Urn
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 2.84
Mean:
	
1.38
RMS: 	 2.01
3.18
11.92
11.92
mm Hg
mm Hg
mm Hg
1.93 ml, 2.51 %
1.87 ml, 2.43 %
4.94 %
Discharge Coefficient 0.639
Performance Index: 0.409
Efficiency Index: 0.389
111
SHELHIGH Inc. Millburn, NJ 07041
* * SHELHIGH Pulse Duplicator System * *
Test No. 	 11 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 3494 	 Valve size: 25 mm 	Mitral Politic
Operator:
	
E. Sean Parker
System Parameters:
	 Heart Rate:
	
72.12 	 bpm
Stroke Volume: 	 76.25 	 ml
Cardiac Output: 	 5.50 	 L/m
Duration of valve cycle: 	 0.83 	 sec.
Forward Flow Phase: 	 0.52 	 sec. 62.31 %
Measured Flow ( L/m ): RMS: 	 13.01 	 L/m
Mean: 	 8.74 	 L/m
Peak: 	 17.36 	 L/m
Measured Pressures (mm Hg): Mean: 5.18 mm Hg
Peak Pressure: 14.70 mm Hg
Pressure at max flow: 14.70 mm Hg
Valve Parameters Closing Volume: 3.79 ml, 	 4.97
Leakage Volume: 1.58 ml, 	 2.08
Regurgitant Fraction: 7.05 %
Effective Orifice Area (sq cm.):
	
Peak: 	 2.46
Mean: 	 1.24
RMS: 	 1.85
%
Discharge Coefficient 	 0.587
Performance Index: 	 0.376
Efficiency Index: 	 0.349
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 9 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 3494 	 Valve size: 25 m m 	 M itral Position
Operator: 	 E. Sean Parker
System Parameters:
Measured Flow ( L/m ):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
Heart Rate:
Stroke Volume:
Cardiac Output:
Duration of valve cycle:
Forward Flow Phase:
14.86 L/m
9.86 L/m
19.36 L/m
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 2.92
Mean: 	 1.49
RMS: 	 2.24
	81.08	 bpm
	
76.08 	 ml
	
6.17 	 L/m
	
0.74 	 sec.
	
0.46 	 sec. 61.88 %
4.58 mm Hg
13.42 mm Hg
13.35 mm Hg
3.09 ml, 4.06 %
3.18 ml, 4.18 %
824 %
Discharge Coefficient: 0.713
Performance Index: 0.457
Efficiency Index: 0.419
RMS:
Mean:
Peak:
System Parameters:
Measured Flow (L/m):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
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SHELHIGH Pulse Duplicator System **
Test No. 	 10 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 3494 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
Heart Rate:
Stroke Volume:
Cardiac Output:
Duration of valve cycle:
Forward Flow Phase:
RIMS:	 16.83 L/m
Mean: 	 11.65 L/m
Peak: 	 21.93 L/m
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 3.13
Mean:
	
1.66
RMS: 	 2.40
	96.15	 bpm
	
81.03 	 m l
	
7.79 	 L/m
	
0.62 	 sec.
	
0.41 	 sec. 66.01 %
5.13 mm Hg
14.05 mm Hg
11.82 mm Hg
2.74 ml, 3.39 %
3.40 ml, 420 %
7.59 %
Discharge Coefficient: 0.764
Performance Index: 0.489
Efficiency Index: 0.452
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* SHELHIGH Pulse Duplicator System * *
Test No. 	 13 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3494 	 valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
101.35 bpm
Stroke Volume: 	 78.73 	 ml
Cardiac Output 	 7.98 	 Urn
Duration of valve cycle: 	 0.59 	 sec.
Forward Flow Phase: 	 0.40 	 sec. 67.11 %
Measured Flow (Um): 	 RMS: 	 16.84 Urn
Mean: 	 11.73 Um
Peak: 	 22.17 Urn
Measured Pressures (mm Hg):
	 Mean: 	 6.74 mm Hg
Peak Pressure: 	 16.80 mm Hg
Pressure at max flow: 	 15.27 mm Hg
Valve Parameters 	 Closing Volume: 	 2.54 ml, 323 %
Leakage Volume: 	 3.89 ml, 4.95 %
Regurgitant Fraction: 	 8.17 	 %
Effective Orifice Area (sq cm.):
	 Peak: 	 2.76 	 Discharge Coefficient 	 0.667
Mean: 	 1.46
	
Performance Index: 	 0.427
RMS: 	 2.10 	 Efficiency Index: 	 0.392
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 14 	 Valve Type: SHELHIGH 	 Serial No. 	 3494 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 112.78 bpm
Stroke Volume: 	 79.66 	 ml
Cardiac Output 	 8.98 	 Um
Duration of valve cycle: 	 0.53 	 sec.
Forward Flow Phase: 	 0.36 	 sec. 68.18 %
Measured Flow (Um): 	 RMS: 	 18.74 Um
Mean: 	 12.98 Urn
Peak: 	 25.56 Urn
Measured Pressures (mm Hg):
	 Mean:
Peak Pressure:
Pressure at max flow:
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 3.41
Mean:
	
1.73
RMS: 	 2.50
5.85
14.97
10.52
mm Hg
mm Hg
mm Hg
3.56 ml, 4.47 %
2.29 ml, 2.88 %
7.35 %
Discharge Coefficient: 0.796
Performance Index: 0.509
Efficiency Index: 0.472
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 15 	 Valve Type: SHELHIGH 	 Serial No. 	 3494 	 Valve sae: 25 mm 	 Wm! Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 118.11 	 bpm
Stroke Volume:
	
79.43 	 ml
Cardiac Output: 	 9.38 	 L/m
Duration of valve cycle: 	 0.51 	 sec.
Forward Flow Phase: 	 0.35 	 sec. 68.50 %
Measured Flow (L/m): 	 RMS: 	 19.44 L/m
Mean: 	 13.48 L/m
Peak: 	 25.99 L/m
Measured Pressures (mm Hg):
	 Mean: 	 6.38 mm Hg
Peak Pressure: 	 15.62 mm Hg
Pressure at max flow: 	 9.40 mm Hg
Valve Parameters
	 Closing Volume: 	 213 ml, 3.44 %
Leakage Volume: 	 2.85 ml, 3.59 %
Regurgitant Fraction: 	 7.02 	 %
Effective Orifice Area (sq cm.):
	 Peak: 	 3.32 	 Discharge Coefficient 	 0.791
Mean: 	 1.72 	 Performance Index: 	 0.506
RMS: 	 2.49 	 Efficiency Index: 	 0.471
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 44 	 Valve Type: SHELHIGH
	 Serial No. 	 2264 	 Valve size: 25 mm 	 Mitral Potion
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 64.10 	 bpm
Stroke Volume: 	 74.30 	 ml
Cardiac Output:
	
4.76 	 L/m
Duration of valve cycle: 	 0.94 	 sec.
Forward Flow Phase:
	
0.58 	 sec. 62.11 %
Measured Flow ( L/m ): 	 RMS: 	 11.16 L/m
Mean:
	
7.60 L/m
Peak: 	 14.03 L/m
Measured Pressures (mm Hg):
	 Mean:
Peak Pressure:
Pressure at max flow:
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 1.69
Mean: 	 0.92
RMS:
	 1.35
7.16
16.27
16.27
mm Hg
mm Hg
mm Hg
4.30 ml, 5.79 %
1.84 ml, 2.48 %
827 %
Discharge Coefficient: 0.429
Performance Index: 0.274
Efficiency Index: 0.252
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* SHELHIGH Pulse Duplicator System * *
Test No. 	 47 	 Valve Type: SHELHIGH 	 Serial No. 	 2264 	 Valve size: 25 mm 	 Mitral Position.
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
78.13 	 bpm
Stroke Volume:
	
73.25 	 m l
Cardiac Output:
	
5.72 	 L/m
Duration of valve cycle:
	
0.77
	 sec.
Forward Flow Phase:
	
0.47 	 sec. 61.17 %
Measured Flow ( L/m ): RMS: 	 13.94 	 L/m
Mean: 	 9.26 	 L/m
Peak: 	 18.37 	 L/m
Measured Pressures (mm Hg): Mean: 5.37 mm Hg
Peak Pressure: 15.30 mm Hg
Pressure at max flow: 15.15 mm Hg
Valve Parameters Closing Volume: 5.61 ml, 	 7.66 %
Leakage Volume: 1.69 ml, 	2.31 %
Regurgitant Fraction: 9.97 %
Effective Orifice Area (sq cm.): Peak: 	 2.56 Discharge Coefficient: 0.618
Mean: 	 1.29 Performance Index: 0.396
RMS: 	 1.94 Efficiency Index: 0.356
Effective Orifice Area (sq cm.):
	 Peak: 	 2.13
Mean: 	 1.11
RMS: 	 1.67
Discharge Coefficient: 	 0.530
Performance Index: 	 0.339
Efficiency Index: 	 0.309
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* SHELHIGH Pulse Duplicator System * *
Test No. 	 46 	 Valve Type: SHELHIGH 	 Serial No. 	 2264 	 Valve size: 25 mm 	 Mara' Positio
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 82.42 	 bpm
Stroke Volume: 	 73.59 	 ml
Cardiac Output:
	
6.07 	 Um
Duration of valve cycle: 	 0.73 	 sec.
Forward Flow Phase: 	 0.44 	 sec. 60.89 %
Measured Flow (Um): RMS:	 14.82 	 Um
Mean: 	 9.85 	 Um
Peak: 	 18.96 	 Urn
Measured Pressures (mm Hg): Mean: 8.25 mm Hg
Peak Pressure: 19.02 mm Hg
Pressure at max flow: 18.80 mm Hg
Valve Parameters Closing Volume: 4.76 ml, 	 6.47
Leakage Volume: 1.91 ml, 	 2.59
Regurgitant Fraction: 9.07 %
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** SHELHIGH Pulse Duplicator System **
Test No. 	 45 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 2264 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 91.46	 bpm
Stroke Volume:
	
74.98 	 ml
Cardiac Output:
	
6.86 	 L/m
Duration of valve cycle: 	 0.66 	 sec.
Forward Flow Phase: 	 0.41 	 sec. 62.96 %
Measured Flow (L/m): 	 RMS: 	 15.99 L/m
Mean: 	 10.76 L/m
Peak: 	 20.46 L/m
Measured Pressures (mm Hg):
	 Mean: 	 5.97 mm Hg
Peak Pressure: 	 15.75 min Hg
Pressure at max flow: 	 14.70 mm Hg
Valve Parameters
	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 2.70
Mean: 	 1.42
RMS: 	 2.11
3.05 ml, 4.06 %
4.04 ml, 5.39 %
9.45 %
Discharge Coefficient 0.672
Performance Index: 0.430
Efficiency Index: 0.390
Effective Orifice Area (sq cm.):
	 Peak: 	 2.91
Mean: 	 1.52
RMS: 	 2.19
Discharge Coefficient 	 0.698
Performance Index: 	 0.446
Efficiency Index: 	 0.416
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 48 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 2264 	 Valve size: 25 mm
	
Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 96.15 	 bpm
Stroke Volume: 	 82.70 	 ml
Cardiac Output 	 7.95 	 L/m
Duration of valve cycle: 	 0.62 	 sec.
Forward Flow Phase: 	 0.42 	 sec. 66.67 %
Measured Flow (L/m): RMS: 	 16.95 	 L/m
Mean: 	 11.77 	 L/m
Peak: 	 22.46 	 L/m
Measured Pressures (mm Hg): Mean: 6.24 mm Hg
Peak Pressure: 16.27 mm Hg
Pressure at max flow: 11.72 mm Hg
Valve Parameters Closing Volume: 3.36 ml, 	 4.07
Leakage Volume: 2.21 ml, 	 2.67
Regurgitant Fraction: 6.74 %
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 49 	 Valve Type: SHELHIGH 	 Serial No. 	 2264 	 Valve size: 25 m m 	Mitral Poston
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 109.49 bpm
Stroke Volume:
	
78.02 	 ml
Cardiac Output
	
8.54 	 L/m
Duration of valve cycle: 	 0.55 	 sec.
Forward Flow Phase: 	 0.37 	 see. 67.65 %
Measured Flow ( L/m ):
Measured Pressures (mm Hg):
Valve Parameters
Effective Orifice Area (sq cm.):
RMS: 	 18.08 L/m
Mean: 	 12.45 L/m
Peak: 	 24.79 L/m
Mean:
Peak Pressure:
Pressure at max flow:
Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Peak: 	 3.18
Mean: 	 1.60
RMS: 	 2.32
6.34 mm Hg
16.15 mm Hg
10.95 mm Hg
	
3.16 	 ml, 	 4.05 %
	
3.00 	 ml, 	 3.85 %
7.90 %
Discharge Coefficient:
Performance Index:
Efficiency Index:
0.738
0.472
0.435
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 50 	 Valve Type: SHELHIGH 	 Serial No. 	 2264 	 Valve size: 25 mm 	 MitralPosition
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 119.05 	 bpm
Stroke Volume:
	
79.00 	 ml
Cardiac Output: 	 9.40 	 L/m
Duration of valve cycle: 	 0.50 	 sec.
Forward Flow Phase: 	 0.35 	 sec. 68.80 VD
Measured Flow (L/m): RMS: 	 19.39 	 L/m
Mean: 	 13.45 	 L/m
Peak: 	 25.94 	 L/m
Measured Pressures (mm Hg): Mean: 6.91 mm Hg
Peak Pressure: 16.55 mm Hg
Pressure at max flow: 9.65 mm Hg
Valve Parameters Closing Volume: 2.76 nil, 	 3.50
. Leakage Volume: 2.39 ml, 	 3.02
Regurgitant Fraction: 6.52 %
Effective Orifice Area (sq cm.):
	 Peak: 	 3.19
Mean: 	 1.65
RMS: 	 2.38
Discharge Coefficlent: 	 0.758
Performance Index: 	 0.485
Efficiency Index: 	 0.45.4
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 65 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3953 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 64.66 	 bpm
Stroke Volume: 	 73.45 	 ml
Cardiac Output: 	 4.75 	 L/m
Duration of valve cycle: 	 0.93 	 sec.
Forward Flow Phase: 	 0.56 	 sec. 60.62 %
Measured Flow ( L/m ): 	 RMS: 	 11.55 L/m
Mean: 	 7.77 L/m
Peak: 	 14.83 L/m
Measured Pressures (mm Hg): 	 Mean:
Peak Pressure:
Pressure at max flow:
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.): 	 Peak: 	 2.43
Mean: 	 127
RMS: 	 1.89
3.90
12.90
12.87
mm Hg
mm Hg
mm Hg
5.19 ml, 7.07 %
2.97 ml, 4.04 %
11.11 %
Discharge Coefficient: 0.601
Performance Index: 0.385
Efficlency Index: 0.342
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 66 	 Valve Type:
	
SHELHIGH
	 Serial No. 	 3953 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 76.53 	 bpm
Stroke Volume: 	 76.78 	 ml
Cardiac Output 	 5.88 	 L/m
Duration of valve cycle: 	 0.78 	 sec,
Forward Flow Phase: 	 0.49 	 sec. 62.83 %
Measured Flow ( L/m ): RMS: 	 13.83 	 L/m
Mean: 	 9.26 	 L/m
Peak: 	 18.69 	 L/m
Measured Pressures (mm Hg): Mean: 4.48 mm Hg
Peak. Pressure: 13,85 mm Hg
Pressure at max flow: 13.72 mm Hg
Valve Parameters Closing Volume: 	 . 4.01 ml, 	 5.23 %
Leakage Volume: 3.69 ml, 	 4.80 %
Regurgitant Fraction: 10.03 %
Effective Orifice Area (sq cm.): Peak: 	 2.85 Discharge Coefficient: 0.672
Mean: 	 1.41 Performance Index: 0.430
RMS: 	 2.11 Efficiency Index: 0.387
("1
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SHELHIGH Pulse Duplicator System **
Test No. 	 67 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3953 	 Valve size: 25 mm 	Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 8427 	 bpm
Stroke Volume: 	 74.38 	 ml
Cardiac Output 	 6.27 	 L/m
Duration of valve cycle: 	 0.71 	 sec.
Forward Flow Phase: 	 0.43 	 sec. 60.23 %
Measured Flow ( L/m ): 	 RMS: 	 15.57 L/m
Mean: 	 10.29 L/m
Peak: 	 19.71 L/m
Measured Pressures (mm Hg): 	 Mean: 	 525 mm Hg
Peak Pressure: 	 14.47 mm Hg
Pressure at max flow: 	 13.97 mm Hg
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 2.78
Mean: 	 1.45
RMS: 	 2.19
3.10 ml, 4.17 %
4.13 ml, 5.55 %
9.72 %
Discharge Coefficient: 0.698
Performance Index: 0.447
Efficiency Index: 0.403
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 68 	 Valve Type: SHELHIGH 	 Serial No. 	 3953 	 Valve size: 25 mm
	
Mitral posit ()
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate:
	
90.91
	 bpm
Stroke Volume:
	
78.16 	 ml
Cardiac Output
	
7.11 	 Um
Duration of valve cycle: 	 0.66 	 sec.
Forward Flow Phase: 	 0.41 	 sec. 62.20 %
Measured Flow (Urn): RMS: 	 16.61 	 Urn
Mean: 	 11.29 	 Urn
Peak: 	 20.62 	 Urn
Measured Pressures (mm Hg): Mean: 5.23 mm Hg
Peak Pressure: 1425 mm Hg
Pressure at max flow: 13.32 mm Hg
Valve Parameters Closing Volume: 3.53 ml, 	 4.51 %
Leakage Volume: 4.72 ml, 	 6.03 %
Regurgitant Fraction: 10.55 %
Effective Orifice Area (sq cm.):
	 Peak: 	 2.91
Mean: 	 1.59
RMS: 	 2.35
• Discharge Coefficient: 0.746
Performance Index: 0.478
Efficiency Index: 0.427
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 69 	 Valve Type: SHELHIGH 	 Serial No. 	 3953 	 Valve 	 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 100.00 	 bpm
Stroke Volume: 	 80.23 	 ml
Cardiac Output: 	 8.02 L/m
Duration of valve cycle: 	 0.60 	 sec.
Forward Flow Phase: 	 0.40 	 sec. 66.89 %
Measured Flow ( L/m ): 	 RMS: 	 16.98L/m
Mean: 	 11.83 L/m
Peak: 	 22.65 L/m
Measured Pressures (mm Hg): 	 Mean:
Peak Pressure:
Pressure at max flow:
Valve Parameters 	 Closing Volume:
Leakage Volume:
Regurgitant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 3.12
Mean: 	 1.63
RMS:
	
2.34
5.50
14.82
11.62
mm Hg
mm Hg
mm Hg
3.28 ml, 4.09 %
3.86 ml, 4.81 %
8.90 %
Discharge Coefficient: 0.745
Performance Index: 0.477
Efficiency Index: 0.434
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SHELHIGH Pulse Duplicator System * *
Test No. 	 70 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3953 	 Valve size: 25 mm 	 Mtn' Positior
Operator. 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 109.49 	 bpm
Stroke Volume: 	 79.92 	 ml
Cardiac Output: 	 8.75 	 L/m
Duration of valve cycle: 	 0.55 	 sec.
Forward Flow Phase: 	 0.37 	 sec. 68.38 %
Measured Flow ( L/m ): 	 RMS: 	 18.11 L/m
Mean: 	 12.61 L/m
Peak: 	 24.58 L/m
Measured Pressures (mm Hg):
	 Mean: 	 5.88 mm Hg
Peak Pressure: 	 15.27 mm Hg
Pressure at max flow: 	 8.52 mm Hg
Valve Parameters
	 Closing Volume:
Leakage Volume:
Regurgirant Fraction:
Effective Orifice Area (sq cm.):
	 Peak: 	 3.27
Mean: 	 1.68
RMS: 	 2.41
3.38 ml, 423 %
3.65 ml, 4.57 %
8.80 %
Discharge Coefficient: 0.768
Performance Index: 0.491
Efficiency Index: 0.448
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* SHELHIGH Pulse Duplicator System **
Test No. 	 71 	 Valve Type: SHELHIGH 	 Serial No. 	 3953 	 Valve 	 25 mm 	Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 121.95 	 bpm
Stroke Volume: 	 79.26 	 ml
Cardiac Output: 	 9.67 	 L/m
Duralion of valve cycle: 	 0.49 	 sec.
Forward Flow Phase: 	 0.34 	 sec. 68.85 %
Measured Flow (L/m): RMS: 	 19.80 	 L/m
Mean: 	 13.81 	 L/m
Peak: 	 25.88 	 L/m
Measured Pressures (mm Hg): Mean: 6.66 mm Hg
Peak Pressure: 15.87 mm Hg
Pressure at max flow: 8.05 mm Hg
Valve Parameters Closing Volume: 3.13 nil, 	 3.95 %
Leakage Volume: 3.15 ml, 	 3.98 %
Regurgirant Fraction: 7.93 %
Effective Orifice Area (sq cm.): Peak: 	 3.24 Discharge Coefficient 0.789
Mean: 	 1.73 Performance Index: 0.505
RMS: 	 2.48 Efficiency Index: 0.465
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 79 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3955 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 60.24 	 bpm
Stroke Volume: 	 70.70 	 ml
Cardiac Output: 	 4.26 	 L/m
Duration of valve cycle: 	 1.00 	 sec.
Forward Flow Phase: 	 0.59 	 sec, 58.96 %
Measured Flow (L/m ): RMS: 	 10.79 	 L/m
Mean: 	 7.17 	 L/m
Peak: 	 13.58 	 L/m
Measured Pressures (Mm Hg): Mean: 2.94 mm Hg
Peak Pressure: 11.17 mm Hg
Pressure at max flow: 11.10 mm Hg
Valve Parameters Closing Volume: 3.56 ml, 	 5.04
Leakage Volume: 3.61 ml, 	 5.10
Regurgitant Fraction: 10.14 %
Effective Orifice Area (sq cm.):
	 Peak: 	 2.56 	 Discharge Coefficient: 	 0.647
Mean: 	 1.35 	 Performance Index: 	 0.414
RMS: 	 2.03 	 Efficiency Index: 	 0.372
Effective Orifice Area (sq cm.): Peak: 2.78
Mean: 1.42
RMS: 2.15
Discharge Coefficient:
Performance Index:
Efficiency Index:
0.683
0.437
0.367
13?
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 80 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 3955 	 Valve size: 25 m m 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 74.26 	 bpm
Stroke Volume: 	 74.12 	 ml
Cardiac Output 	 5.50 	 Urn
Duration of valve cycle: 	 0.81 	 sec.
Forward Flow Phase: 	 0.48 	 sec. 60.00 %
Measured Flow (Urn): 	 RMS: 	 13.69 Um
Mean: 	 9.08 Um
Peak: 	 17.73 Um
Measured Pressures (mm Hg): 	 Mean: 	 4.24 mm Hg
Peak Pressure: 	 13.15 mm Hg
Pressure at max flow: 	 12.87 mm Hg
Valve Parameters 	 'Closing Volume: 	 6.73 ml, 	 9.08 %
Leakage Volume: 	 5.14 ml, 	 6.93 %
Regurgitant Fraction: 	 16.02 %
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 81 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3955 	 Valve size: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 86.21 	 bpm
Stroke Volume: 	 74.32 	 m l
Cardiac Output 	 6.41 	 Um
Duration of valve cycle: 	 0.70 	 sec.
Forward Flow Phase: 	 0.40 	 sec. 58.05 %
Measured Flow (Um): RMS: 	 16.56 	 Um
Mean: 	 10.91 	 Um
Peak: 	 20.17 	 Um
Measured Pressures (mm Hg): Mean: 5.35 mm Hg
Peak Pressure: 14.17 mm Hg
Pressure at max flow: 13.57 mm Hg
Valve Parameters Closing Volume: 9.82 ml, 	 13.22 %
Leakage Volume: 1.35 ml, 	 1.82 %
Regurgitant Fraction: 15.03 %
Effective Orifice Area (sq cm.): Peak: 	 2.82 Discharge Coefficient 0.736
Mean: 	 1.52 Performance Index: 0.471
RMS: 	 2.31 Efficiency Index: 0.400
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** SHELHIGH Pulse Duplicator System * *
Test No. 	 82 	 Valve Type: SHELHIGH 	 Serial No. 	 3955 	 Valve se: 25 mm 	 Mitral Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 93.17 	 bpm
Stroke Volume: 	 76.56 	 ml
Cardiac Output:
	
7.13 	 L/m
Duration of valve cycle: 	 0.64 	 sec.
Forward Flow Phase: 	 0.39 	 sec. 60.49 %
Measured Flow ( L/m ): RMS: 	 17.19 	 L/m
Mean: 	 11.65 	 L/m
Peak: 	 20.93 	 L/m
Measured Pressures (mm Hg): Mean: 5.56 mm Hg
Peak Pressure: 14.47 mm Hg
Pressure at max flow: 13.12 mm Hg
Valve Parameters Closing Volume: 10.94 ml, 	 14.29 %
Leakage Volume: 0.02 ml, 	 0.03 %
Regurgitant Fraction: 14.32 %
Effective Orifice Area (sq cm.): Peak: 	 2.87 Discharge Coefficient 0.750
Mean:
	 1.60 Performance Index: 0.480
RMS: 	 2.36 Efficiency Index: 0.411
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* * SHELHIGH Pulse Duplicator System * *
Test No. 	 83 	 Valve Type: SHELHIGH 	 Serial No. 	 3955 	 Valve size: 25 mm 	Vital Position
Operator: 	 E. Sean Parker
System Parameters:
	 Heart Rate: 	 97.40 	 bpm
Stroke Volume: 	 79.60 	 m l
Cardiac Output 	 7.75 	 L/m
Duration of valve cycle: 	 0.62 	 sec.
Forward Flow Phase: 	 0.38 	 sec. 62.50 %
Measured Flow (L/m ): RMS: 	 17.90 	 L/m
Mean: 	 1224 	 L/m
Peak: 	 22.16 	 L/m
Measured Pressures (mm Hg): Mean: 5.72 mm Hg
Peak Pressure: 14.75 mm Hg
Pressure at max flow: 11.32 mm Hg
Valve Parameters Closing Volume: . 5.30 ml, 	6.66 %
Leakage Volume: 5.50 ml, 	6.91 %
Regurgitant Fraction: 13.57 %
Effective Orifice Area (sq cm.): Peak: 	 2.99 Discharge Coefficient: 0.769
Mean: 	 1.65 Performance Index: 0.492
RMS: 	 2.42 Efficiency Index: 0.425
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* * SHELHIGH Pulse Duplicator System **
Test No. 	 85 	 Valve Type:
	
SHELHIGH 	 Serial No. 	 3955 	 Valve size: 25 mm 	 Mitral Positioi
Operator: 	 E. Sean Parker
System Parameters: 	 Heart Rate: 	 110.29 	 bpm
Stroke Volume: 	 77.44 	 ml
Cardiac Output: 	 8.54 	 L/m
Duration of valve cycle: 	 0.54 	 sec.
Forward Flow Phase: 	 0.35 	 sec. 63.97 %
Measured Flow (L/m ): RMS: 	 19.35 	 L/m
Mean: 	 13.16 	 L/m
Peak: 	 24.98 	 L/m
Measured Pressures (mm Hg): Mean: 6.54 mm Hg
Peak Pressure: 15.72 mm Hg
Pressure at max flow: 9.90 mm Hg
Valve Parameters Closing Volume: 9.15 ml, 	 11.82
Leakage Volume: 0.01 ml, 	 0.02
Regurgitant Fraction: 11.84 %
Effective Orifice Area (sq cm.):
	 Peak: 	 3.16 	 Discharge Coefficient: 	 0.778
Mean: 	 1.66 	 Performance Index: 	 0.498
RMS: 	 2.44 	 Efficiency Index: 	 0.439
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** SHELHIGH Pulse Duplicator System:* *
Test No. 	 84 	 Valve Type: 	 SHELHIGH 	 Serial No. 	 3955 	 Valve size: 25 mm 	Mitral Position
Operator:
	
E. Sean Parker
System Parameters: 	 Heart Rate: 	 119.05 bpm
Stroke Volume: 	 78.56 	 ml
Cardiac Output: 	 9.35 	 L/m
Duration of valve cycle: 	 0.50 	 sec.
Forward Flow Phase: 	 0.33 	 sec. 65.35 %
Measured Flow ( L/m ): RMS: 	 20.56 	 L/m
Mean: 	 14.09 	 L/m
Peak: 	 25.98 	 L/m
Measured Pressures (mm Hg): Mean: 9.65 mm Hg
Peak Pressure: 19.87 mm Hg
Pressure at max flow: 11.32 mm Hg
Valve Parameters Closing Volume: 4.82 ml, 	 6.14 %
Leakage Volume: 3.38 ml, 	 4.30 %
Regurgitant Fraction: 10.44 %
Effective Orifice Area (sq cm.): Peak: 	 2.70 Discharge Coefficient: 0.680
Mean: 	 1.46 Performance Index: 0.435
RMS: 	 2.14 Efficiency Index: 0.390
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